Robrecht Pieters
#133,717
Most Influential Person Now
Robrecht Pieters's AcademicInfluence.com Rankings
Robrecht Pieterslaw Degrees
Law
#2432
World Rank
#3022
Historical Rank
Common Law
#96
World Rank
#105
Historical Rank
International Law
#505
World Rank
#636
Historical Rank
Download Badge
Law
Why Is Robrecht Pieters Influential?
(Suggest an Edit or Addition)Robrecht Pieters's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia (2002) (1509)
- A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification study. (2009) (827)
- FBW7 mutations in leukemic cells mediate NOTCH pathway activation and resistance to γ-secretase inhibitors (2007) (675)
- Childhood Acute Lymphoblastic Leukemia: Progress Through Collaboration. (2015) (644)
- Gene-expression patterns in drug-resistant acute lymphoblastic leukemia cells and response to treatment. (2004) (601)
- Gene expression-based chemical genomics identifies rapamycin as a modulator of MCL1 and glucocorticoid resistance. (2006) (501)
- L‐asparaginase treatment in acute lymphoblastic leukemia (2011) (488)
- A treatment protocol for infants younger than 1 year with acute lymphoblastic leukaemia (Interfant-99): an observational study and a multicentre randomised trial (2007) (452)
- Inhibition of FLT3 in MLL. Validation of a therapeutic target identified by gene expression based classification. (2003) (417)
- Biological and therapeutic aspects of infant leukemia. (2000) (402)
- Oncogenic IL7R gain-of-function mutations in childhood T-cell acute lymphoblastic leukemia (2011) (370)
- Integrated transcript and genome analyses reveal NKX2-1 and MEF2C as potential oncogenes in T cell acute lymphoblastic leukemia. (2011) (328)
- Significant difference in outcome for adolescents with acute lymphoblastic leukemia treated on pediatric vs adult protocols in the Netherlands (2004) (311)
- In childhood acute lymphoblastic leukemia, blasts at different stages of immunophenotypic maturation have stem cell properties. (2008) (291)
- Imatinib after induction for treatment of children and adolescents with Philadelphia-chromosome-positive acute lymphoblastic leukaemia (EsPhALL): a randomised, open-label, intergroup study (2012) (273)
- Duplication of the MYB oncogene in T cell acute lymphoblastic leukemia (2007) (266)
- PHF6 mutations in T-cell acute lymphoblastic leukemia (2010) (264)
- Independent prognostic value of BCR-ABL1-like signature and IKZF1 deletion, but not high CRLF2 expression, in children with B-cell precursor ALL. (2013) (245)
- NUP98/NSD1 characterizes a novel poor prognostic group in acute myeloid leukemia with a distinct HOX gene expression pattern. (2011) (237)
- Relation between age, immunophenotype and in vitro drug resistance in 395 children with acute lymphoblastic leukemia–implications for treatment of infants (1998) (235)
- Relation of cellular drug resistance to long-term clinical outcome in childhood acute lymphoblastic leukaemia (1991) (233)
- Successful Therapy Reduction and Intensification for Childhood Acute Lymphoblastic Leukemia Based on Minimal Residual Disease Monitoring: Study ALL10 From the Dutch Childhood Oncology Group. (2016) (232)
- FLT3 internal tandem duplication in 234 children with acute myeloid leukemia: prognostic significance and relation to cellular drug resistance. (2003) (229)
- Novel prognostic subgroups in childhood 11q23/MLL-rearranged acute myeloid leukemia: results of an international retrospective study. (2009) (225)
- Clinical outcome of children with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia treated between 1995 and 2005. (2008) (217)
- The recurrent SET-NUP214 fusion as a new HOXA activation mechanism in pediatric T-cell acute lymphoblastic leukemia. (2007) (210)
- Inhibition of glycolysis modulates prednisolone resistance in acute lymphoblastic leukemia cells. (2009) (201)
- Differential mRNA expression of Ara-C-metabolizing enzymes explains Ara-C sensitivity in MLL gene-rearranged infant acute lymphoblastic leukemia. (2003) (194)
- Sustaining innovation and improvement in the treatment of childhood cancer: lessons from high-income countries. (2013) (192)
- Anti-Mullerian hormone is a sensitive serum marker for gonadal function in women treated for Hodgkin's lymphoma during childhood. (2007) (185)
- The cryptic chromosomal deletion del(11)(p12p13) as a new activation mechanism of LMO2 in pediatric T-cell acute lymphoblastic leukemia. (2006) (184)
- A prospective study on drug monitoring of PEGasparaginase and Erwinia asparaginase and asparaginase antibodies in pediatric acute lymphoblastic leukemia. (2013) (182)
- MicroRNA characterize genetic diversity and drug resistance in pediatric acute lymphoblastic leukemia (2011) (182)
- Acute lymphoblastic leukemia in children with Down syndrome: a retrospective analysis from the Ponte di Legno study group. (2014) (181)
- Increased expression of the breast cancer resistance protein (BCRP) in relapsed or refractory acute myeloid leukemia (AML) (2002) (176)
- Tumor-specific down-regulation of the tumor necrosis factor-related apoptosis-inducing ligand decoy receptors DcR1 and DcR2 is associated with dense promoter hypermethylation. (2002) (175)
- In Vitro Cellular Drug Resistance and Prognosis in Newly Diagnosed Childhood Acute Lymphoblastic Leukemia (1997) (174)
- Favorable prognostic impact of NPM1 gene mutations in childhood acute myeloid leukemia, with emphasis on cytogenetically normal AML (2009) (173)
- Diagnostic tool for the identification of MLL rearrangements including unknown partner genes. (2005) (171)
- Identification of genes associated with chemotherapy crossresistance and treatment response in childhood acute lymphoblastic leukemia. (2005) (170)
- Different drug sensitivity profiles of acute myeloid and lymphoblastic leukemia and normal peripheral blood mononuclear cells in children with and without Down syndrome. (2002) (168)
- Targeting FLT3 in primary MLL-gene-rearranged infant acute lymphoblastic leukemia. (2005) (165)
- Adaptation of the rapid automated tetrazolium dye based (MTT) assay for chemosensitivity testing in childhood leukemia. (1988) (163)
- Polymorphisms in folate-related genes and risk of pediatric acute lymphoblastic leukemia. (2009) (154)
- A randomized trial investigating an exercise program to prevent reduction of bone mineral density and impairment of motor performance during treatment for childhood acute lymphoblastic leukemia (2009) (151)
- Specific promoter methylation identifies different subgroups of MLL-rearranged infant acute lymphoblastic leukemia, influences clinical outcome, and provides therapeutic options. (2009) (150)
- Molecular‐genetic insights in paediatric T‐cell acute lymphoblastic leukaemia (2008) (148)
- Gene expression profiling-based dissection of MLL translocated and MLL germline acute lymphoblastic leukemia in infants. (2010) (145)
- Prognostic significance of molecular-cytogenetic abnormalities in pediatric T-ALL is not explained by immunophenotypic differences (2008) (145)
- Sensitivity to L-asparaginase is not associated with expression levels of asparagine synthetase in t(12;21)+ pediatric ALL. (2003) (142)
- Improved outcome with hematopoietic stem cell transplantation in a poor prognostic subgroup of infants with mixed-lineage-leukemia (MLL)-rearranged acute lymphoblastic leukemia: results from the Interfant-99 Study. (2010) (141)
- Incidence, Medical Resource Utilisation and Costs of Hyperuricemia and Tumour Lysis Syndrome in Patients with Acute Leukaemia and Non-Hodgkin's Lymphoma in Four European Countries (2003) (140)
- NOTCH1 and/or FBXW7 mutations predict for initial good prednisone response but not for improved outcome in pediatric T-cell acute lymphoblastic leukemia patients treated on DCOG or COALL protocols (2010) (140)
- The human equilibrative nucleoside transporter 1 mediates in vitro cytarabine sensitivity in childhood acute myeloid leukaemia (2005) (139)
- Outcome of Infants Younger Than 1 Year With Acute Lymphoblastic Leukemia Treated With the Interfant-06 Protocol: Results From an International Phase III Randomized Study. (2019) (137)
- B-cell precursor acute lymphoblastic leukemia cells use tunneling nanotubes to orchestrate their microenvironment. (2015) (136)
- The expression of 70 apoptosis genes in relation to lineage, genetic subtype, cellular drug resistance, and outcome in childhood acute lymphoblastic leukemia. (2006) (135)
- Clinical relevance of Wilms tumor 1 gene mutations in childhood acute myeloid leukemia. (2009) (135)
- The heterogeneity of pediatric MLL-rearranged acute myeloid leukemia (2011) (134)
- Biological background of pediatric medulloblastoma and ependymoma: a review from a translational research perspective. (2008) (132)
- Effect of polymorphisms in folate-related genes on in vitro methotrexate sensitivity in pediatric acute lymphoblastic leukemia. (2005) (132)
- Leukemia-associated NF1 inactivation in patients with pediatric T-ALL and AML lacking evidence for neurofibromatosis. (2008) (131)
- IKZF1 status as a prognostic feature in BCR-ABL1-positive childhood ALL. (2014) (129)
- Comparison of the rapid automated MTT-assay with a dye exclusion assay for chemosensitivity testing in childhood leukaemia. (1989) (129)
- Role of folylpolyglutamate synthetase and folylpolyglutamate hydrolase in methotrexate accumulation and polyglutamylation in childhood leukemia. (1999) (129)
- The prognostic significance of membrane transport-associated multidrug resistance (MDR) proteins in leukemia. (2000) (128)
- WT1 mutations in T-ALL. (2009) (127)
- Prospective study on incidence, risk factors, and long-term outcome of osteonecrosis in pediatric acute lymphoblastic leukemia. (2011) (123)
- Flash survey on severe acute respiratory syndrome coronavirus-2 infections in paediatric patients on anticancer treatment (2020) (121)
- Differential expression and prognostic significance of SOX genes in pediatric medulloblastoma and ependymoma identified by microarray analysis. (2008) (118)
- Gene expression profiles predictive of outcome and age in infant acute lymphoblastic leukemia: a Children's Oncology Group study. (2012) (117)
- NALP3 inflammasome up-regulation and CASP1 cleavage of the glucocorticoid receptor causes glucocorticoid resistance in leukemia cells (2015) (116)
- Integrative analysis of type-I and type-II aberrations underscores the genetic heterogeneity of pediatric acute myeloid leukemia (2011) (115)
- Second malignant neoplasms after treatment of childhood acute lymphoblastic leukemia. (2013) (112)
- The significance of PTEN and AKT aberrations in pediatric T-cell acute lymphoblastic leukemia (2012) (108)
- MDR 1 expression is an independent prognostic factor for response and survival in de novo acute myeloid leukaemia (1997) (108)
- Evaluation of gene expression signatures predictive of cytogenetic and molecular subtypes of pediatric acute myeloid leukemia (2011) (107)
- Long-term results of Dutch Childhood Oncology Group studies for children with acute lymphoblastic leukemia from 1984 to 2004 (2010) (107)
- DRUG SENSITIVITY ASSAYS IN LEUKAEMIA AND LYMPHOMA (1990) (106)
- Components of the metabolic syndrome in 500 adult long-term survivors of childhood cancer. (2009) (106)
- The outcome of molecular-cytogenetic subgroups in pediatric T-cell acute lymphoblastic leukemia: a retrospective study of patients treated according to DCOG or COALL protocols. (2006) (105)
- Decrease in peripheral muscle strength and ankle dorsiflexion as long‐term side effects of treatment for childhood cancer (2008) (105)
- Gene expression signatures predictive of early response and outcome in high-risk childhood acute lymphoblastic leukemia: A Children's Oncology Group Study [corrected]. (2008) (103)
- NUP98/JARID1A is a novel recurrent abnormality in pediatric acute megakaryoblastic leukemia with a distinct HOX gene expression pattern (2013) (100)
- Expression of miR-196b is not exclusively MLL-driven but is especially linked to activation of HOXA genes in pediatric acute lymphoblastic leukemia (2010) (98)
- Genomewide identification of prednisolone-responsive genes in acute lymphoblastic leukemia cells. (2005) (98)
- Leukemic stem cells in childhood high-risk ALL/t(9;22) and t(4;11) are present in primitive lymphoid-restricted CD34+CD19- cells. (2005) (98)
- Glucocorticoid receptor alpha, beta and gamma expression vs in vitro glucocorticod resistance in childhood leukemia (2004) (94)
- Biology and treatment of acute lymphoblastic leukemia. (2010) (94)
- Frequencies and prognostic impact of RAS mutations in MLL-rearranged acute lymphoblastic leukemia in infants (2013) (94)
- Resistance to different classes of drugs is associated with impaired apoptosis in childhood acute lymphoblastic leukemia. (2003) (93)
- Polymorphisms in folate-related genes: association with side effects of high-dose methotrexate in childhood acute lymphoblastic leukemia (2008) (92)
- mRNA expression levels of methotrexate resistance-related proteins in childhood leukemia as determined by a standardized competitive template-based RT-PCR method (2000) (91)
- Inhibin B is superior to FSH as a serum marker for spermatogenesis in men treated for Hodgkin's lymphoma with chemotherapy during childhood. (2007) (91)
- Influence of Cranial Radiotherapy on Outcome in Children With Acute Lymphoblastic Leukemia Treated With Contemporary Therapy. (2016) (91)
- Improved flow cytometric detection of minimal residual disease in childhood acute lymphoblastic leukemia (2013) (90)
- Discovery of new microRNAs by small RNAome deep sequencing in childhood acute lymphoblastic leukemia (2011) (89)
- MDR1 gene-related clonal selection and P-glycoprotein function and expression in relapsed or refractory acute myeloid leukemia. (2001) (89)
- Contributions of mucosal immune cells to methotrexate-induced mucositis. (2006) (88)
- Clear cell sarcomas of the kidney registered on International Society of Pediatric Oncology (SIOP) 93-01 and SIOP 2001 protocols: a report of the SIOP Renal Tumour Study Group. (2013) (87)
- Clustering of hypermethylated genes in neuroblastoma (2003) (86)
- IL-7 Receptor Mutations and Steroid Resistance in Pediatric T cell Acute Lymphoblastic Leukemia: A Genome Sequencing Study (2016) (86)
- Asparagine synthetase expression is linked with L-asparaginase resistance in TEL-AML1-negative but not TEL-AML1-positive pediatric acute lymphoblastic leukemia. (2005) (85)
- Posterior reversible encephalopathy syndrome in childhood cancer. (2011) (85)
- In vitro drug sensitivity of cells from children with leukemia using the MTT assay with improved culture conditions. (1990) (83)
- Decrease in motor performance in children with cancer is independent of the cumulative dose of vincristine (2006) (82)
- High incidence of t(7;12)(q36;p13) in infant AML but not in infant ALL, with a dismal outcome and ectopic expression of HLXB9 (2006) (82)
- Expression of a human homing receptor (CD44) in lymphoid malignancies and related stages of lymphoid development. (1990) (82)
- Pediatric aggressive fibromatosis (2005) (82)
- Identification of Tumor‐Related Proteins by Proteomic Analysis of Cerebrospinal Fluid from Patients with Primary Brain Tumors (2003) (81)
- EVI1 overexpression in distinct subtypes of pediatric acute myeloid leukemia (2010) (78)
- Association of high-level MCL-1 expression with in vitro and in vivo prednisone resistance in MLL-rearranged infant acute lymphoblastic leukemia. (2010) (78)
- BCR-ABL1-like cases in pediatric acute lymphoblastic leukemia: a comparison between DCOG/Erasmus MC and COG/St. Jude signatures (2015) (77)
- Characterization of CEBPA mutations and promoter hypermethylation in pediatric acute myeloid leukemia (2011) (76)
- Myocyte enhancer factor 2C in hematopoiesis and leukemia (2014) (75)
- Long-term nephrotoxicity in adult survivors of childhood cancer. (2013) (75)
- Outcome of congenital acute lymphoblastic leukemia treated on the Interfant-99 protocol. (2009) (75)
- Dasatinib in children and adolescents with relapsed or refractory leukemia: results of the CA180-018 phase I dose-escalation study of the Innovative Therapies for Children with Cancer Consortium. (2013) (74)
- Cellular drug resistance in childhood acute myeloid leukemia is related to chromosomal abnormalities. (2002) (73)
- Pharmacokinetics, pharmacodynamics, efficacy, and safety of a new recombinant asparaginase preparation in children with previously untreated acute lymphoblastic leukemia: a randomized phase 2 clinical trial. (2008) (73)
- Prognostic value of rare IKZF1 deletion in childhood B-cell precursor acute lymphoblastic leukemia: an international collaborative study (2016) (72)
- MEK and PI3K-AKT inhibitors synergistically block activated IL7 receptor signaling in T-cell acute lymphoblastic leukemia (2016) (72)
- Connectivity mapping identifies HDAC inhibitors for the treatment of t(4;11)-positive infant acute lymphoblastic leukemia (2012) (72)
- Pan-European multicentre economic evaluation of recombinant urate oxidase (rasburicase) in prevention and treatment of hyperuricaemia and tumour lysis syndrome in haematological cancer patients (2003) (72)
- PTEN microdeletions in T-cell acute lymphoblastic leukemia are caused by illegitimate RAG-mediated recombination events. (2014) (70)
- Glucocorticoid-induced glucocorticoid-receptor expression and promoter usage is not linked to glucocorticoid resistance in childhood ALL. (2006) (69)
- Pediatric acute myeloid leukemia with t(8;16)(p11;p13), a distinct clinical and biological entity: a collaborative study by the International-Berlin-Frankfurt-Munster AML-study group. (2012) (69)
- Genetic Variations in the Glucocorticoid Receptor Gene Are Not Related to Glucocorticoid Resistance in Childhood Acute Lymphoblastic Leukemia (2005) (68)
- Methotrexate-induced side effects are not due to differences in pharmacokinetics in children with Down syndrome and acute lymphoblastic leukemia (2010) (68)
- Immature MEF2C-dysregulated T-cell leukemia patients have an early T-cell precursor acute lymphoblastic leukemia gene signature and typically have non-rearranged T-cell receptors (2014) (66)
- Recurrent abnormalities can be used for risk group stratification in pediatric AMKL: a retrospective intergroup study. (2016) (66)
- RAS pathway mutations as a predictive biomarker for treatment adaptation in pediatric B-cell precursor acute lymphoblastic leukemia (2017) (65)
- How I treat infant leukemia. (2019) (65)
- Prognostic significance of additional cytogenetic aberrations in 733 de novo pediatric 11q23/MLL-rearranged AML patients: results of an international study. (2011) (65)
- Cellular drug resistance profiles that might explain the prognostic value of immunophenotype and age in childhood acute lymphoblastic leukemia. (1993) (64)
- Decreased PARP and procaspase-2 protein levels are associated with cellular drug resistance in childhood acute lymphoblastic leukemia. (2005) (64)
- Decreased serum anti-Müllerian hormone levels in girls with newly diagnosed cancer. (2014) (64)
- Silencing of the tumor suppressor gene FHIT is highly characteristic for MLL gene rearranged infant acute lymphoblastic leukemia (2006) (63)
- Disturbed CXCR4/CXCL12 axis in paediatric precursor B‐cell acute lymphoblastic leukaemia (2014) (63)
- Elevated S100A8/S100A9 expression causes glucocorticoid resistance in MLL-rearranged infant acute lymphoblastic leukemia (2012) (62)
- Tyrosine kinase fusion genes in pediatric BCR-ABL1-like acute lymphoblastic leukemia (2016) (62)
- Prognostic significance of high-level FLT3 expression in MLL-rearranged infant acute lymphoblastic leukemia. (2007) (62)
- The SWI/SNF chromatin-remodeling complex and glucocorticoid resistance in acute lymphoblastic leukemia. (2008) (60)
- In vitro drug resistance profiles of adult versus childhood acute lymphoblastic leukaemia (2000) (60)
- The Seventh International Childhood Acute Lymphoblastic Leukemia Workshop Report: Palermo, Italy, January 29–30, 2005 (2005) (60)
- Imatinib treatment of paediatric Philadelphia chromosome-positive acute lymphoblastic leukaemia (EsPhALL2010): a prospective, intergroup, open-label, single-arm clinical trial. (2018) (60)
- High-risk childhood acute lymphoblastic leukemia in first remission treated with novel intensive chemotherapy and allogeneic transplantation (2013) (59)
- The toxicity of very prolonged courses of PEGasparaginase or Erwinia asparaginase in relation to asparaginase activity, with a special focus on dyslipidemia (2014) (59)
- Multidrug resistance genes in infant acute lymphoblastic leukemia: Ara-C is not a substrate for the breast cancer resistance protein (2004) (57)
- Different types of non-P-glycoprotein mediated multiple drug resistance in children with relapsed acute lymphoblastic leukaemia. (1992) (57)
- Expression of the leucocyte integrin LFA-1 (CD11a/CD18) and its ligand ICAM-1 (CD54) in lymphoid malignancies is related to lineage derivation and stage of differentiation but not to tumor grade. (1991) (57)
- Electroejaculation as a method of fertility preservation in boys diagnosed with cancer: a single-center experience and review of the literature. (2014) (56)
- Abdominal Radiotherapy: A Major Determinant of Metabolic Syndrome in Nephroblastoma and Neuroblastoma Survivors (2012) (56)
- IN VITRO RESISTANCE TO CYTOSINE ARABINOSIDE, NOT TO DAUNORUBICIN, IS ASSOCIATED WITH THE RISK OF RELAPSE IN DE NOVO ACUTE MYELOID LEUKAEMIA (1996) (56)
- A new recurrent 9q34 duplication in pediatric T-cell acute lymphoblastic leukemia (2006) (56)
- The SIOPE strategic plan: a European cancer plan for children and adolescents (2015) (56)
- High anaplastic lymphoma kinase immunohistochemical staining in neuroblastoma and ganglioneuroblastoma is an independent predictor of poor outcome. (2012) (55)
- L-Asparaginase and the effect of age on coagulation and fibrinolysis in childhood acute lymphoblastic leukemia (2008) (55)
- Management and treatment of osteonecrosis in children and adolescents with acute lymphoblastic leukemia (2014) (54)
- Activating FLT3 mutations in CD4+/CD8- pediatric T-cell acute lymphoblastic leukemias. (2005) (53)
- Src kinase-induced phosphorylation of annexin A2 mediates glucocorticoid resistance in MLL-rearranged infant acute lymphoblastic leukemia (2013) (53)
- Predictive value of minimal residual disease in Philadelphia-chromosome-positive acute lymphoblastic leukemia treated with imatinib in the European intergroup study of post-induction treatment of Philadelphia-chromosome-positive acute lymphoblastic leukemia, based on immunoglobulin/T-cell receptor a (2017) (52)
- STAT3 mediates oncogenic addiction to TEL-AML1 in t(12;21) acute lymphoblastic leukemia. (2013) (52)
- Genetic and metabolic determinants of methotrexate-induced mucositis in pediatric acute lymphoblastic leukemia (2014) (52)
- The Metabolic Syndrome in Adult Survivors of Childhood Cancer, a Review (2010) (51)
- Up-regulation of asparagine synthetase expression is not linked to the clinical response L-asparaginase in pediatric acute lymphoblastic leukemia. (2006) (51)
- Long-term endocrine side effects of childhood Hodgkin's lymphoma treatment: a review. (2012) (51)
- Obesity Is Underestimated Using Body Mass Index and Waist-Hip Ratio in Long-Term Adult Survivors of Childhood Cancer (2012) (51)
- MLL fusion-driven activation of CDK6 potentiates proliferation in MLL-rearranged infant ALL (2014) (50)
- The relevance of PTEN-AKT in relation to NOTCH1-directed treatment strategies in T-cell acute lymphoblastic leukemia (2016) (50)
- New cellular markers at diagnosis are associated with isolated central nervous system relapse in paediatric B‐cell precursor acute lymphoblastic leukaemia (2016) (50)
- No difference between prednisolone and dexamethasone treatment in bone mineral density and growth in long term survivors of childhood acute lymphoblastic leukemia (2006) (49)
- Differentially expressed miRNAs in cytogenetic and molecular subtypes of pediatric acute myeloid leukemia (2012) (49)
- Gain of 1q is a marker of poor prognosis in Wilms' tumors (2013) (49)
- Flash Survey on SARS-CoV-2 Infections in Pediatric Patients on anti-Cancer Treatment (2020) (49)
- Methotrexate resistance in relation to treatment outcome in childhood acute lymphoblastic leukemia (2015) (48)
- Drug Resistance in Leukemia and Lymphoma III (2012) (48)
- Cost-analysis of treatment of childhood acute lymphoblastic leukemia with asparaginase preparations: the impact of expensive chemotherapy (2013) (48)
- Motor performance and functional exercise capacity in survivors of pediatric acute lymphoblastic leukemia (2013) (48)
- The HDAC inhibitor panobinostat (LBH589) exerts in vivo anti-leukaemic activity against MLL-rearranged acute lymphoblastic leukaemia and involves the RNF20/RNF40/WAC-H2B ubiquitination axis (2018) (48)
- Tumor suppressor IKZF1 mediates glucocorticoid resistance in B-cell precursor acute lymphoblastic leukemia (2016) (47)
- ‘Educational symposium on long-term results of large prospective clinical trials for childhood acute lymphoblastic leukemia (1985–2000)’ (2010) (47)
- Outcome of Children With Hypodiploid Acute Lymphoblastic Leukemia: A Retrospective Multinational Study. (2019) (47)
- Differential Methotrexate Resistance in Childhood T- Versus Common/PreB-Acute Lymphoblastic Leukemia Can Be Measured by an In Situ Thymidylate Synthase Inhibition Assay, But Not by the MTT Assay (1999) (46)
- Folate concentration dependent transport activity of the Multidrug Resistance Protein 1 (ABCC1). (2004) (46)
- Impaired dexamethasone-related increase of anticoagulants is associated with the development of osteonecrosis in childhood acute lymphoblastic leukemia (2008) (46)
- Multidrug resistance proteins and folate supplementation: therapeutic implications for antifolates and other classes of drugs in cancer treatment (2006) (46)
- In vitro sensitivity and cross-resistance to deoxynucleoside analogs in childhood acute leukemia. (2006) (45)
- Classification Of Ex Vivo Methotrexate Resistance In Acute Lymphoblastic and Myeloid Leukaemia (2000) (45)
- Tumor suppressors BTG1 and IKZF1 cooperate during mouse leukemia development and increase relapse risk in B-cell precursor acute lymphoblastic leukemia patients (2016) (44)
- New genetic abnormalities and treatment response in acute lymphoblastic leukemia. (2009) (44)
- Various components of the insulin‐like growth factor system in tumor tissue, cerebrospinal fluid and peripheral blood of pediatric medulloblastoma and ependymoma patients (2008) (44)
- Systematic review of the addition of vincristine plus steroid pulses in maintenance treatment for childhood acute lymphoblastic leukaemia – an individual patient data meta‐analysis involving 5659 children (2010) (44)
- Expression of the glucocorticoid receptor and its isoforms in relation to glucocorticoid resistance in childhood acute lymphocytic leukemia. (2005) (43)
- Identification of Novel Biomarkers in Pediatric Primitive Neuroectodermal Tumors and Ependymomas by Proteome-Wide Analysis (2007) (42)
- Frequency of WT1 and 11p15 constitutional aberrations and phenotypic correlation in childhood Wilms tumour patients. (2012) (42)
- Low frequency of DNMT3A mutations in pediatric AML, and the identification of the OCI-AML3 cell line as an in vitro model (2012) (42)
- Hydrocortisone as an Intervention for Dexamethasone-Induced Adverse Effects in Pediatric Patients With Acute Lymphoblastic Leukemia: Results of a Double-Blind, Randomized Controlled Trial. (2016) (42)
- Polymorphisms in genes involved in vincristine pharmacokinetics or pharmacodynamics are not related to impaired motor performance in children with leukemia. (2010) (42)
- Bone mineral density at diagnosis determines fracture rate in children with acute lymphoblastic leukemia treated according to the DCOG-ALL9 protocol. (2014) (41)
- BCR-ABL 1-like cases in pediatric acute lymphoblastic leukemia : a comparison between DCOG / Erasmus MC and COG / St (2015) (41)
- Talking about Death with Children with Incurable Cancer: Perspectives from Parents. (2015) (41)
- Bone marrow magnetic resonance studies in childhood leukemia. Evaluation of osteonecrosis (1987) (40)
- Relation of 5'-nucleotidase and phosphatase activities with immunophenotype, drug resistance and clinical prognosis in childhood leukemia. (1992) (40)
- Towards targeted therapy for infant acute lymphoblastic leukaemia (2006) (40)
- Raised blast glutathione levels are associated with an increased risk of relapse in childhood acute lymphocytic leukemia. (2001) (39)
- Renin‐induced hypertension in Wilms tumor patients (2007) (39)
- Do P-glycoprotein and major vault protein (MVP/LRP) expression correlate with in vitro daunorubicin resistance in acute myeloid leukemia? (1999) (39)
- MEK inhibition is a promising therapeutic strategy for MLL-rearranged infant acute lymphoblastic leukemia patients carrying RAS mutations (2016) (39)
- Hypoxanthine‐guanine phosphoribosyl‐transferase in childhood leukemia: Relation with immunophenotype, in vitro drug resistance and clinical prognosis (1992) (39)
- Recurrent deletions of IKZF1 in pediatric acute myeloid leukemia (2015) (38)
- Bone mineral density after childhood cancer in 346 long-term adult survivors of childhood cancer (2015) (37)
- High BRE expression in pediatric MLL-rearranged AML is associated with favorable outcome (2010) (37)
- Telomere length and telomerase complex mutations in pediatric acute myeloid leukemia (2012) (37)
- The negative impact of being underweight and weight loss on survival of children with acute lymphoblastic leukemia (2015) (37)
- Validation of the United Kingdom copy-number alteration classifier in 3239 children with B-cell precursor ALL. (2019) (37)
- The N-myc paradox: N-myc overexpression in neuroblastomas is associated with sensitivity as well as resistance to apoptosis. (2003) (36)
- Lentiviral gene transfer into human and murine hematopoietic stem cells: size matters (2016) (36)
- Decreased induction morbidity and mortality following modification to induction therapy in infants with acute lymphoblastic leukemia enrolled on AALL0631: A report from the children's oncology group (2015) (36)
- Bone marrow immunophenotyping by flow cytometry in refractory cytopenia of childhood (2014) (36)
- Pharmacogenetic risk factors for altered bone mineral density and body composition in pediatric acute lymphoblastic leukemia (2010) (36)
- Biology and treatment of acute lymphoblastic leukemia. (2008) (36)
- Identification of apolipoprotein A-II in cerebrospinal fluid of pediatric brain tumor patients by protein expression profiling. (2006) (35)
- Genetic variation may modify ovarian reserve in female childhood cancer survivors. (2013) (35)
- In vitro efficacy of forodesine and nelarabine (ara-G) in pediatric leukemia. (2011) (35)
- NKL homeobox genes in leukemia (2012) (35)
- Absence of global hypomethylation in promoter hypermethylated Mixed Lineage Leukaemia-rearranged infant acute lymphoblastic leukaemia. (2013) (35)
- Cellular drug resistance in acute myeloid leukemia: literature review and preliminary analysis of an ongoing collaborative study. (1999) (35)
- Circumvention of methotrexate resistance in childhood leukemia subtypes by rationally designed antifolates. (1999) (34)
- Infant acute lymphoblastic leukemia: Lessons learned and future directions (2009) (34)
- Ex vivo activity of methotrexate versus novel antifolate inhibitors of dihydrofolate reductase and thymidylate synthase against childhood leukemia cells. (1998) (34)
- Immunophenotypic cell lineage and in vitro cellular drug resistance in childhood relapsed acute lymphoblastic leukaemia. (2005) (34)
- No prognostic impact of the WT1 gene single nucleotide polymorphism rs16754 in pediatric acute myeloid leukemia. (2010) (33)
- Improved survival for children and young adolescents with acute myeloid leukemia: a Dutch study on incidence, survival and mortality (2018) (33)
- Characterization of a pediatric T-cell acute lymphoblastic leukemia patient with simultaneous LYL1 and LMO2 rearrangements (2012) (33)
- JAK2 aberrations in childhood B-cell precursor acute lymphoblastic leukemia (2016) (32)
- Towards personalized therapy in pediatric acute lymphoblastic leukemia: RAS mutations and prednisolone resistance (2015) (31)
- Chemical genomic screening identifies LY294002 as a modulator of glucocorticoid resistance in MLL-rearranged infant ALL (2014) (31)
- T-cell receptor Vβ CDR3 oligoclonality frequently occurs in childhood refractory cytopenia (MDS-RC) and severe aplastic anemia (2008) (30)
- NUTM1 is a recurrent fusion gene partner in B-cell precursor acute lymphoblastic leukemia associated with increased expression of genes on chromosome band 10p12.31-12.2 (2019) (30)
- Protection against chemotherapy induced mucositis by TGF‐β2 in childhood cancer patients: Results from a randomized cross‐over study (2007) (30)
- Bone mineral density, growth, and thyroid function in long-term survivors of pediatric Hodgkin's lymphoma treated with chemotherapy only. (2009) (30)
- [Adolescents with acute lymphatic leukaemia achieve significantly better results when treated following Dutch paediatric oncology protocols than with adult protocols]. (2005) (29)
- The role of impaired transport in (pre)clinical resistance to methotrexate: insights on new antifolates. (1998) (29)
- Normal karyotype is a poor prognostic factor in myeloid leukemia of Down syndrome: a retrospective, international study (2014) (28)
- Autophagy inhibition as a potential future targeted therapy for ETV6-RUNX1-driven B-cell precursor acute lymphoblastic leukemia (2018) (28)
- Methotrexate resistance in relapsed childhood acute lymphoblastic leukaemia (2000) (28)
- CD34 expression is associated with poor survival in pediatric T‐cell acute lymphoblastic leukemia (2008) (28)
- KIAA1524: A novel MLL translocation partner in acute myeloid leukemia. (2011) (28)
- Emotional Distress in 652 Dutch Very Long-term Survivors of Childhood Cancer, Using the Hospital Anxiety and Depression Scale (HADS) (2013) (28)
- Anaplastic lymphoma kinase (ALK) inhibitor response in neuroblastoma is highly correlated with ALK mutation status, ALK mRNA and protein levels (2011) (27)
- Decreased ovarian function is associated with obesity in very long-term female survivors of childhood cancer. (2013) (27)
- Differential methotrexate resistance in childhood T- versus common/preB-acute lymphoblastic leukemia can be measured by an in situ thymidylate synthase inhibition assay, but not by the MTT assay. (1999) (27)
- D-HPLC analysis of the entire FLT3 gene in MLL rearranged and hyperdiploid acute lymphoblastic leukemia (2007) (27)
- Relation between genetic variants of the ataxia telangiectasia-mutated (ATM) gene, drug resistance, clinical outcome and predisposition to childhood T-lineage acute lymphoblastic leukaemia (2005) (27)
- Beneficial and harmful effects of anthracyclines in the treatment of childhood acute lymphoblastic leukaemia: a systematic review and meta-analysis. (2009) (26)
- High IGSF4 expression in pediatric M5 acute myeloid leukemia with t(9;11)(p22;q23). (2011) (26)
- Absence of mutations in the deoxycytidine kinase (dCK) gene in patients with relapsed and/or refractory acute myeloid leukemia (AML) (2001) (26)
- Increased total-Tau levels in cerebrospinal fluid of pediatric hydrocephalus and brain tumor patients. (2008) (26)
- Impact of treatment reduction for childhood acute lymphoblastic leukemia on serum immunoglobulins and antibodies against vaccine‐preventable diseases (2012) (25)
- Clinical Implications of Minimal Residual Disease Detection in Infants With KMT2A-Rearranged Acute Lymphoblastic Leukemia Treated on the Interfant-06 Protocol (2020) (25)
- Treatment factors rather than genetic variation determine metabolic syndrome in childhood cancer survivors. (2013) (25)
- Gene Expression Profiling Identifies BAX-δ as a Novel Tumor Antigen in Acute Lymphoblastic Leukemia (2005) (25)
- Expression Levels of TEL, AML1, and the Fusion Products TEL-AML1 and AML1-TEL versus Drug Sensitivity and Clinical Outcome in t(12;21)-Positive Pediatric Acute Lymphoblastic Leukemia (2005) (25)
- Germline variation in the MTHFR and MTRR genes determines the nadir of bone density in pediatric acute lymphoblastic leukemia: a prospective study. (2011) (25)
- No prognostic effect of additional chromosomal abnormalities in children with acute lymphoblastic leukemia and 11q23 abnormalities (2005) (25)
- Low frequency of MLL-partial tandem duplications in paediatric acute myeloid leukaemia using MLPA as a novel DNA screenings technique. (2010) (25)
- MicroRNAs Characterize Genetic Diversity and Drug Sensitivity in Pediatric Acute Lymphoblastic Leukemia. (2009) (25)
- Tumor Suppressor IKZF 1 Mediates Glucocorticoid Resistance in B-cell Precursor Acute Lymphoblastic Leukemia (2015) (25)
- Pharmacokinetics of high‐dose methotrexate in infants treated for acute lymphoblastic leukemia (2009) (25)
- Does dexamethasone induce more neuropsychological side effects than prednisone in pediatric acute lymphoblastic leukemia? A systematic review (2014) (25)
- Copy number alterations in B-cell development genes, drug resistance, and clinical outcome in pediatric B-cell precursor acute lymphoblastic leukemia (2019) (25)
- A risk score including microdeletions improves relapse prediction for standard and medium risk precursor B‐cell acute lymphoblastic leukaemia in children (2018) (25)
- The potential of clofarabine in MLL-rearranged infant acute lymphoblastic leukaemia. (2015) (24)
- Pharmacokinetics of daunorubicin and daunorubicinol in infants with leukemia treated in the interfant 99 protocol (2010) (24)
- The long-term impact of in vitro drug sensitivity on risk stratification and treatment outcome in acute lymphoblastic leukemia of childhood (CoALL 06-97) (2011) (24)
- Differential expression of p73 isoforms in relation to drug resistance in childhood T-lineage acute lymphoblastic leukaemia (2006) (24)
- T-cell Acute Lymphoblastic Leukemia: A Roadmap to Targeted Therapies. (2020) (24)
- Inhibiting Polo-like kinase 1 causes growth reduction and apoptosis in pediatric acute lymphoblastic leukemia cells (2013) (24)
- In vitro cytotoxicity of mitoxantrone, daunorubicin and doxorubicin in untreated childhood acute leukemia. (1994) (23)
- BCL-2 expression in childhood leukemia versus spontaneous apoptosis, drug induced apoptosis, and in vitro drug resistance. (1999) (23)
- Self‐limiting sternal tumors of childhood (SELSTOC) (2010) (23)
- The synergism of MCL1 and glycolysis on pediatric acute lymphoblastic leukemia cell survival and prednisolone resistance (2013) (23)
- The miR-1206 microRNA variant is associated with methotrexate-induced oral mucositis in pediatric acute lymphoblastic leukemia (2017) (23)
- The recurrent SET-NUP 214 fusion as a new HOXA activation mechanism in pediatric T-cell acute lymphoblastic leukemia (2008) (23)
- The role of 5'nucleotidase in therapy-resistance of childhood leukemia. (1988) (23)
- Cytogenetics and outcome of infants with acute lymphoblastic leukemia and absence of MLL rearrangements (2013) (22)
- Frequency and prognostic implications of JAK 1-3 aberrations in Down syndrome acute lymphoblastic and myeloid leukemia (2011) (22)
- Significant difference in outcome for adolescents with acute lymphoblastic leukemia (ALL) treated on pediatric versus adult ALL protocols. (2003) (22)
- Endocrine sequelae and metabolic syndrome in adult long-term survivors of childhood acute myeloid leukemia. (2013) (22)
- Endocrine late sequelae in long-term survivors of childhood non-Hodgkin lymphoma. (2012) (22)
- Expression of the outcome predictor in acute leukemia 1 (OPAL1) gene is not an independent prognostic factor in patients treated according to COALL or St Jude protocols. (2006) (22)
- No evidence of increased asparagine levels in the bone marrow of patients with acute lymphoblastic leukemia during asparaginase therapy (2013) (22)
- Reduced versus intensive chemotherapy for childhood acute lymphoblastic leukemia: impact on lymphocyte compartment composition. (2011) (21)
- Methotrexate‐induced mucositis in mucin 2‐deficient mice (2007) (21)
- Novel murine B‐cell lymphoma/leukemia model to study BCL2‐driven oncogenesis (2005) (21)
- High concordance of subtypes of childhood acute lymphoblastic leukemia within families: lessons from sibships with multiple cases of leukemia (2012) (21)
- Recurrent translocation t(10;17)(p15;q21) in minimally differentiated acute myeloid leukemia results in ZMYND11/MBTD1 fusion (2016) (21)
- Immunological phenotype of lymphoid cells in regenerating bone marrow of children after treatment for acute lymphoblastic leukemia (1988) (21)
- Changes in hypercoagulability by asparaginase: a randomized study between two asparaginases (2006) (21)
- Prognostic Value of Rare IKZF1 deletions in Childhood B-Cell Precursor Acute Lymphoblastic Leukemia: An International Collaborative Study (2014) (21)
- Acute Activation of Metabolic Syndrome Components in Pediatric Acute Lymphoblastic Leukemia Patients Treated with Dexamethasone (2016) (20)
- In vitro anthracycline cross-resistance pattern in childhood acute lymphoblastic leukaemia. (1995) (20)
- A possible role for methotrexate in the treatment of childhood acute myeloid leukaemia, in particular for acute monocytic leukaemia. (2001) (20)
- Outcomes of paediatric patients with B-cell acute lymphocytic leukaemia with ABL-class fusion in the pre-tyrosine-kinase inhibitor era: a multicentre, retrospective, cohort study. (2021) (20)
- Favorable outcome of NUTM1-rearranged infant and pediatric B cell precursor acute lymphoblastic leukemia in a collaborative international study (2021) (20)
- Mu class glutathione S‐transferase mRNA isoform expression in acute lymphoblastic leukaemia (2003) (20)
- Determinants of quality of life during induction therapy in pediatric acute lymphoblastic leukemia (2014) (20)
- MLL Fusion Driven Activation of CDK6 Potentiates Proliferation in MLL-rearranged Infant ALL (2012) (20)
- Impact of two independent bone marrow samples on minimal residual disease monitoring in childhood acute lymphoblastic leukaemia (2006) (19)
- NRIP3: a novel translocation partner of MLL detected in a pediatric acute myeloid leukemia with complex chromosome 11 rearrangements (2009) (19)
- MicroRNA-106b~25 cluster is upregulated in relapsed MLL-rearranged pediatric acute myeloid leukemia (2016) (18)
- Management of Hyperuricemia with Rasburicase Review (2004) (18)
- Gene expression profiling identifies BAX-delta as a novel tumor antigen in acute lymphoblastic leukemia. (2005) (18)
- A phase 1/2, open‐label, dose‐escalation study of midostaurin in children with relapsed or refractory acute leukaemia (2018) (18)
- [Growth hormone therapy and leukemia]. (1992) (18)
- High relapse rate in children with non-advanced nodular lymphocyte predominant Hodgkin's lymphoma (NLPHL or nodular paragranuloma) treated with chemotherapy only (2006) (18)
- The clinical relevance of BAALC and ERG expression levels in pediatric AML (2013) (18)
- Lack of expression of the chondroitin sulphate proteoglycan neuron‐glial antigen 2 on candidate stem cell populations in paediatric acute myeloid leukaemia/abn(11q23) and acute lymphoblastic leukaemia/t(4;11) (2006) (17)
- Pediatric Acute Lymphoblastic Leukemia: Efficacy and safety of recombinant E. coli-asparaginase in infants (less than one year of age) with acute lymphoblastic leukemia (2013) (17)
- Clinical and molecular genetic characterization of wild-type MLL infant acute lymphoblastic leukemia identifies few recurrent abnormalities (2016) (17)
- A validated novel continuous prognostic index to deliver stratified medicine in pediatric acute lymphoblastic leukemia. (2020) (17)
- Adrenal function in adult long-term survivors of nephroblastoma and neuroblastoma. (2012) (17)
- PHF6 mutations in paediatric acute myeloid leukaemia (2016) (17)
- MAPK-ERK is a central pathway in T-cell acute lymphoblastic leukemia that drives steroid resistance (2021) (16)
- Successful management of extreme hypertriglyceridemia in a child with acute lymphoblastic leukemia by temporarily omitting dexamethasone while continuing asparaginase (2012) (16)
- GeneticVariations in the Glucocorticoid Receptor GeneAre Not Related to Glucocorticoid Resistance in Childhood Acute Lymphoblastic Leukemia (2005) (16)
- Aggravated bone density decline following symptomatic osteonecrosis in children with acute lymphoblastic leukemia (2015) (16)
- Methotrexate-induced mucositis in mucin 2-deficient mice. (2006) (16)
- Disturbed CXCR4/CXCL12 Axis In Pediatric Precursor B-Cell Acute Lymphoblastic Leukemia (2013) (16)
- Antileukemic Efficacy of BET Inhibitor in a Preclinical Mouse Model of MLL-AF4+ Infant ALL (2018) (16)
- Rearranged Infant Acute Lymphoblastic Leukemia. (2008) (15)
- Mapping epigenetic regulator gene mutations in cytogenetically normal pediatric acute myeloid leukemia (2014) (15)
- Impact of reduced chemotherapy treatment for good risk childhood acute lymphoblastic leukaemia on infectious morbidity * (2011) (15)
- The effect of leucovorin rescue therapy on methotrexate-induced oral mucositis in the treatment of paediatric ALL: A systematic review. (2019) (15)
- Targeting FLT 3 in primary MLL-gene – rearranged infant acute lymphoblastic leukemia (2005) (15)
- NUP98/JARID1A Is a New Recurrent Genetic Abnormality in Pediatric Acute Megakaryoblastic Leukemia with a Distinct HOX -Gene Expression Pattern (2012) (15)
- Long-term follow up of pediatric Philadelphia positive acute lymphoblastic leukemia treated with the EsPhALL2004 study: high white blood cell count at diagnosis is the strongest prognostic factor (2018) (14)
- High frequency of copy number alterations in myeloid leukaemia of Down syndrome (2012) (14)
- Epigenetic drug combination induces genome-wide demethylation and altered gene expression in neuro-ectodermal tumor-derived cell lines (2013) (14)
- The association of aberrant folylpolyglutamate synthetase splicing with ex vivo methotrexate resistance and clinical outcome in childhood acute lymphoblastic leukemia (2016) (14)
- Efficacy and safety of recombinant E. coli asparaginase in children with previously untreated acute lymphoblastic leukemia: A randomized multicenter study of the Dutch Childhood Oncology Group (2018) (14)
- MN1 overexpression is driven by loss of DNMT3B methylation activity in inv(16) pediatric AML (2018) (14)
- Patient-derived oral mucosa organoids as an in vitro model for methotrexate induced toxicity in pediatric acute lymphoblastic leukemia (2020) (14)
- The effect of cytostatic drug treatment on intestine-specific transcription factors Cdx2, GATA-4 and HNF-1α in mice (2006) (14)
- Alterations in Epithelial and Mesenchymal Intestinal Gene Expression During Doxorubicin-Induced Mucositis in Mice (2007) (14)
- CD73 (5′-nucleotidase) expression has no prognostic value in children with acute lymphoblastic leukemia (2011) (14)
- Expression of 5'-Nucleotidase (CD73) Related to Other Differentiation Antigens in Leukemias of B-Cell Lineage (1991) (14)
- BCOR and BCORL1 mutations in pediatric acute myeloid leukemia (2013) (14)
- Is there a relationship between in vitro drug resistance and level of minimal residual disease as detected by polymerase chain reaction at the end of induction therapy in childhood acute lymphoblastic leukaemia? (2002) (13)
- Glucocorticoid sensitisation in Mixed Lineage Leukaemia-rearranged acute lymphoblastic leukaemia by the pan-BCL-2 family inhibitors gossypol and AT-101. (2014) (13)
- High expression of CD40 on B-cell precursor acute lymphoblastic leukemia blasts is an independent risk factor associated with improved survival and enhanced capacity to up-regulate the death receptor CD95. (2006) (13)
- Prognostic value of minimal residual disease measured by flow-cytometry in two cohorts of infants with acute lymphoblastic leukemia treated according to either MLL-Baby or Interfant protocols (2020) (13)
- The role of genetic polymorphisms in the thymidylate synthase (TYMS) gene in methotrexate-induced oral mucositis in children with acute lymphoblastic leukemia (2018) (13)
- Chemotherapy Does Not Influence Intestinal Amino Acid Uptake in Children (2007) (13)
- Gonadal function recovery in very long-term male survivors of childhood cancer. (2013) (13)
- Desensitization protocol should not be used in acute lymphoblastic leukemia patients with silent inactivation of PEGasparaginase (2014) (13)
- Different expression of glutathione S-transferase alpha, mu and pi in childhood acute lymphoblastic and myeloid leukaemia. (1999) (13)
- ARE CHILDREN WITH LYMPHOBLASTIC LEUKAEMIA RESISTANT TO 6-MERCAPTOPURINE BECAUSE OF 5'-NUCLEOTIDASE? (1987) (13)
- Immunophenotyping as a guide for targeted therapy. (2003) (12)
- Effect of the histone deacetylase inhibitor depsipeptide on B-cell differentiation in both TEL-AML1-positive and negative childhood acute lymphoblastic leukemia. (2005) (12)
- Classification of pediatric acute myeloid leukemia based on miRNA expression profiles (2017) (12)
- A decrease in vitamin D levels is associated with methotrexate-induced oral mucositis in children with acute lymphoblastic leukemia (2018) (12)
- Adenosine deaminase and purine nucleoside phosphorylase in childhood lymphoblastic leukemia: relation with differentiation stage, in vitro drug resistance and clinical prognosis. (1992) (12)
- Steroids and risk of osteonecrosis in ALL: take a break. (2012) (12)
- Expression of GSTM isoforms in childhood acute lymphoblastoid leukaemia (2003) (11)
- Expression of 5'-nucleotidase (CD73) related to other differentiation antigens in leukemias of B-cell lineage. (1991) (11)
- The limited screening value of insulin‐like growth factor‐i as a marker for alterations in body composition in very long‐term adult survivors of childhood cancer (2012) (11)
- Gonadal function in boys with newly diagnosed cancer before the start of treatment. (2016) (11)
- Role of mutation independent constitutive activation of FLT3 in juvenile myelomonocytic leukemia (2007) (11)
- Multiclonal complexity of pediatric acute lymphoblastic leukemia and the prognostic relevance of subclonal mutations (2020) (11)
- Outcome of Infants Less Than One Year of Age with Acute Lymphoblastic Leukemia Treated with the Interfant-99 Protocol. (2006) (11)
- 1008PDZUMA-4 preliminary results: phase 1 study of KTE-C19 chimeric antigen receptor T cell therapy in pediatric and adolescent patients (pts) with relapsed/refractory acute lymphoblastic leukemia (R/R ALL) (2017) (11)
- Nuclear magnetic resonance imaging of bone marrow in childhood leukaemia. (1988) (11)
- High nerve growth factor receptor (p75NTR) expression is a favourable prognostic factor in paediatric B cell precursor‐acute lymphoblastic leukaemia (2007) (10)
- WT 1 mutations in TALL (2009) (10)
- The thirteenth international childhood acute lymphoblastic leukemia workshop report: La Jolla, CA, USA, December 7–9, 2011 (2013) (10)
- A European paediatric cancer mission: aspiration or reality? (2019) (10)
- Glutathione in childhood acute leukaemias. (1999) (10)
- Dasatinib in Children and Adolescents with Relapsed or Refractory Leukemia: Interim Results of the CA180-018 Phase I Study from the ITCC Consortium. (2008) (10)
- Comparison oftherapid automated MTT-assay withadyeexclusion assayforchemosensitivity testing inchildhood leukaemia (1989) (10)
- Predicting the neurobehavioral side effects of dexamethasone in pediatric acute lymphoblastic leukemia (2016) (10)
- Sensitivity to purine analogues in childhood leukemia assessed by the automated MTT-assay. (1989) (10)
- The clinical phenotype of YWHAE‐NUTM2B/E positive pediatric clear cell sarcoma of the kidney (2016) (9)
- High STAP1 expression in DUX4-rearranged cases is not suitable as therapeutic target in pediatric B-cell precursor acute lymphoblastic leukemia (2018) (9)
- Health‐related fitness in very long‐term survivors of childhood cancer: A cross‐sectional study (2018) (9)
- Infants with acute lymphoblastic leukemia: no evidence for high methotrexate resistance (2002) (9)
- Prognostic significance of acid alpha-naphthyl acetate esterase and acid phosphatase in childhood acute lymphoblastic leukemia. (1987) (9)
- ANGIOPOIETIN1 - a Novel Factor Implicated In MLL-Rearranged Acute Lymphoblastic Leukemia and Regulated In a Fusion Gene-Dependent Manner (2010) (8)
- Population Pharmacokinetics of Native Escherichia Coli Asparaginase (2012) (8)
- Cellular drug resistance in childhood leukemia (2005) (8)
- Global methylation in relation to methotrexate-induced oral mucositis in children with acute lymphoblastic leukemia (2018) (8)
- Pyruvate kinase M2 and prednisolone resistance in acute lymphoblastic leukemia (2009) (8)
- Abl-interactor 2 (ABI2): a novel MLL translocation partner in acute myeloid leukemia. (2012) (8)
- BTG1 deletions do not predict outcome in Down syndrome acute lymphoblastic leukemia (2013) (8)
- Dasatinib (SPRYCEL®) in Children and Adolescents with Relapsed or Refractory Leukemia: Preliminary Results of the CA180018 Phase I/II Study from the ITCC Consortium. (2007) (8)
- Eating behavior during dexamethasone treatment in children with acute lymphoblastic leukemia (2017) (8)
- Defects in the DNA Mismatch Repair System Do Not Contribute to the Development of Childhood Wilms Tumors (2012) (8)
- Downregulation of Axl in non-MYCN amplified neuroblastoma cell lines reduces migration. (2013) (8)
- Genetic variation and bone mineral density in long‐term adult survivors of childhood cancer (2016) (8)
- Daily Life Physical Activity in Long-Term Survivors of Nephroblastoma and Neuroblastoma (2013) (8)
- [Acute lymphoblastic leukaemia in children and adolescents: chance of cure now higher than 80%]. (2010) (8)
- Folates provoke cellular efflux and drug resistance of substrates of the multidrug resistance protein 1 (MRP1) (2014) (8)
- Ammonia Levels Should Not Be Used as a Surrogate Marker of Levels of Asparaginase Activity in Acute Lymphoblastic Leukemia Patients (2016) (7)
- OSTEONECROSIS FOLLOWING CHEMOTHERAPY FOR LEUKEMIA (1989) (7)
- MicroRNA signature in BCR–ABL1-like and BCR–ABL1-positive childhood acute lymphoblastic leukemia: similarities and dissimilarities (2014) (7)
- Perceived and actual motor competence of children treated for cancer with vincristine containing chemotherapy (2008) (7)
- Fibroblast growth factor receptor signaling in pediatric B-cell precursor acute lymphoblastic leukemia (2019) (7)
- Effect of post-consolidation regimen on symptomatic osteonecrosis in three DCOG acute lymphoblastic leukemia protocols (2020) (7)
- Efficacy and Safety of Imatinib on Top of BFM-Like Chemotherapy in Pediatric Patients with Ph+/BCR-ABL+ Acute Lymphoblastic Leukemia (Ph+ALL). the EsPhALL Study (2011) (7)
- A Phase 1/2, Open-Label, Dose-Escalation Study of Midostaurin in Pediatric Patients (Pts) with Relapsed or Refractory (R/R) Acute Leukemia: Final Results of Study ITCC-024 (CPKC412A2114) (2015) (7)
- Bone Mineral Density At Diagnosis Determines Fracture Rate in Children Treated According to the DCOG-ALL9 Protocol (2012) (7)
- INTERNATIONAL COLLABORATIVE TREATMENT PROTOCOL FOR INFANTS UNDER ONE YEAR WITH ACUTE LYMPHOBLASTIC OR BIPHENOTYPIC LEUKEMIA (2015) (6)
- Recurrent NR3C1 Aberrations at First Diagnosis Relate to Steroid Resistance in Pediatric T-Cell Acute Lymphoblastic Leukemia Patients (2020) (6)
- Abstract A19: Epigenetic drug combination induces genome-wide demethylation and altered gene expression in neuro-ectodermal tumor-derived cell lines (2014) (6)
- Report On Excessive Induction Toxicity in Infants with ALL Enrolled On COG Protocol AALL0631: A Children's Oncology Group Study. (2009) (6)
- The Negative Impact of Underweight and Weight Loss on Survival of Children with Acute Lymphoblastic Leukemia (2014) (6)
- Biology and Treatment of Infant Leukemias (2003) (6)
- Dasatinib In Children and Adolescents with Relapsed or Refractory Leukemia: Results of the CA180018 Phase 1 Dose-Escalation Study of the Innovative Therapies for Children with Cancer (ITCC) Consortium (2010) (6)
- Cranial irradiation does not result in pituitary–gonadal axis dysfunction in very long-term male survivors of childhood acute lymphoblastic leukemia (2009) (6)
- Identification of Genes Transcriptionally Responsive to the Loss of MLL Fusions in MLL-Rearranged Acute Lymphoblastic Leukemia (2015) (6)
- Drug Resistance in Children with Relapsed Acute Lymphoblastic Leukemia (1992) (6)
- Hydrocortisone does not influence glucocorticoid sensitivity of acute lymphoblastic leukemia cells (2015) (6)
- Changes in intracellular folate metabolism during high-dose methotrexate and Leucovorin rescue therapy in children with acute lymphoblastic leukemia (2019) (6)
- Outcome of Infants Younger Than 1 Year with Acute Lymphoblastic Leukemia Treated with the Interfant-06 Protocol; Results from an International Randomised Study (2018) (6)
- Versican expression is an adverse prognostic factor in MLL-rearranged infant acute lymphoblastic leukaemia. (2016) (6)
- Specific Promoter CpG Island Methylation Patterns Identify Different Subgroups of MLL - Rearranged Infant Acute Lymphoblastic Leukemia, and Define Clinical Outcome (2008) (6)
- MDR‐1 C3435T gene polymorphism does not correlate with P‐Glycoprotein expression and function in acute myeloid leukemia (2003) (6)
- Online Fluorescent Method to Assess BCRP/ABCG2 Activity in Suspension Cells (2004) (6)
- In Vitro Drug Resistance in Childhood Acute Lymphoblastic Leukemia in Relation to Age and Immunophenotype (1992) (6)
- CBL mutations do not frequently occur in paediatric acute myeloid leukaemia (2012) (6)
- Minimal residual disease and outcome characteristics in infant KMT2A-germline acute lymphoblastic leukaemia treated on the Interfant-06 protocol (2021) (6)
- Toxicity of Very Prolonged Pegasparaginase and Erwinia Asparaginase Courses in Relation to Asparaginase Activity Levels with a Special Focus on Dyslipidemia (2014) (5)
- Flowcytometric evaluation of cerebrospinal fluid in childhood ALL identifies CNS involvement better then conventional cytomorphology (2020) (5)
- Microarray-based identification of new targets for specific therapies in pediatric leukemia. (2007) (5)
- Endocrine Sequelae and Metabolic Syndrome in Adult Long-Term Survivors of Childhood Acute Myeloid Leukemia (2012) (5)
- The clinical value of follow‐up examinations in childhood T‐cell acute lymphoblastic leukemia and T‐cell non‐Hodgkin's lymphoma (2007) (5)
- Obesity independently influences gonadal function in very long‐term adult male survivors of childhood cancer (2014) (5)
- Letter to the editor: gonadal function after childhood ovarian surgery. (2013) (5)
- Circumvention of glucocorticoid resistance in childhood leukemia. (2008) (5)
- Childhood leukaemia: towards improved tailored therapy. (2010) (5)
- Acute Lymphoblastic Leukemia in Children with Down Syndrome: A Report From the Ponte Di Legno Study Group (2011) (5)
- Preclinical efficacy of gemcitabine in MLL-rearranged infant acute lymphoblastic leukemia (2020) (4)
- Cytotoxic Effects of Vitamin A in Combination with Vincristine, Daunorubicin and 6‐Thioguanine upon Cells from Lymphoblastic Leukemic Patients (1991) (4)
- Impaired dexamethasone-related increase of anticoagulants is associated with development of osteonecrosis in childhood acute lymphoblastic leukaemia (2009) (4)
- TELAML1-Positive ALL: A Discordant Genotype (2005) (4)
- High Expression of the Ca2+-Binding Proteins S100A8 and S100A9 Cause Glucocorticoid Resistance in MLL-Rearranged Infant Acute Lymphoblastic Leukemia. (2009) (4)
- Towards Personalized Therapy in Pediatric Acute Lymphoblastic Leukemia; Ras Mutations and Prednisolone Resistance (2014) (4)
- A Gene Expression Connectivity Map Identifies Rapamycin as a Glucocorticoid Resistance Reversal Agent in Lymphoblastic Leukemia. (2005) (4)
- ETV6 Aberrations Are a Recurrent Event in Pediatric Acute Myeloid Leukemia with Poor Clinical Outcome (2014) (4)
- Repeats in the kringle IV encoding domains in the Apo(a) gene and serum lipoprotein(a) level do not contribute to the risk for avascular necrosis of the bone (AVN) in pediatric acute lymphoblastic leukemia (2006) (4)
- Identification and characterization of relapse-initiating cells in MLL-rearranged infant ALL by single-cell transcriptomics (2021) (4)
- Wilms’ Tumor 1 Gene Mutations in Childhood Acute Myeloid Leukemia: A New Prognostic factor with Implications for MRD Detection (2008) (4)
- A Double Blind Randomised Clinical Trial to Prevent Serious Side Effects of Dexamethasone during Pediatric Acute Lymphoblastic Leukemia Treatment (2015) (4)
- Nucleophosmin Gene Mutations Identify a Favorable Risk Group in Childhood Acute Myeloid Leukemia with a Normal Karyotype. (2007) (4)
- High IGSF 4 expression in pediatric M 5 acute myeloid leukemia with t ( 9 ; 11 ) ( p 22 ; q 23 ) * (2010) (4)
- Prognostic Value of Minimal Residual Disease Measured By Flow Cytometry in Two Cohorts of Infants with Acute Lymphoblastic Leukemia Treated with MLL-Baby and Interfant Protocols in Large Multicenter Networks (2019) (4)
- Response to the letter to the editor: 1q gain is a frequent finding in preoperatively treated Wilms tumors, but of limited prognostic value for risk satisfaction in the SIOP2009/Gesellschaft für Pädiatrische Onkologie und Hämatologie (GPOH) trial (2015) (4)
- Absence of SBDS mutations in sporadic paediatric acute myeloid leukaemia (2013) (4)
- In Vitro Drug Resistance in Childhood Acute Myeloid Leukemia: a Preliminary Analysis (1998) (3)
- BCR-ABL1-Like Cases In Pediatric Acute Lymphoblastic Leukemia: A Comparison Between COG/St. Jude and Dutch DCOG Signatures (2013) (3)
- Decitabine mildly attenuates MLL‐rearranged acute lymphoblastic leukemia in vivo, and represents a poor chemo‐sensitizer (2020) (3)
- NF1 Microdeletions in Pediatric MLL -Rearranged AML and T-ALL: A Novel Mechanism for RAS Activation. (2007) (3)
- Myeloid Leukemia of Down Syndrome: The Results of An International Retrospective Study (2010) (3)
- Lack of cross-resistance between prednisolone and methotrexate in childhood acute lymphoblastic leukemia? A preliminary analysis. (1999) (3)
- Leukemia associated NF1 inactivation in pediatric T-ALL and AML patients lacking evidence for neurofibromatosis (2008) (3)
- NUTM1-Rearranged Infant and Pediatric B Cell Precursor Acute Lymphoblastic Leukemia: A Good Prognostic Subtype Identified in a Collaborative International Study (2020) (3)
- Connectivity Mapping Identifies HDAC Inhibitors as Suitable Candidates for the Treatment of t(4;11)-Positive Acute Lymphoblastic Leukemia In Infants (2010) (3)
- MDR 1 gene – related clonal selection and P-glycoprotein function and expression in relapsed or refractory acute myeloid leukemia (2001) (3)
- Somatic thrombopoietin (THPO) gene mutations in childhood myeloid leukemias (2015) (3)
- Does modulation of P-glycoprotein have clinical relevance in pediatric acute myeloid leukemia? (2006) (3)
- Upfront Treatment Influences the Composition of Genetic Alterations in Relapsed Pediatric B-Cell Precursor Acute Lymphoblastic Leukemia (2020) (3)
- Correlation of In Vitro Drug Resistance Assessed by the MTT Assay with Long Term Clinical Outcome in Childhood Acute Lymphoblastic Leukemia (1992) (3)
- Unique BHLHB3 overexpression in pediatric acute myeloid leukemia with t(6;11)(q27;q23) (2014) (3)
- Sensitivity to L-Asparaginase is not associated with expression levels of asparagine synthetase in t(12;21) positive pediatric ALL. Running title: asparagine synthetase in t(12;21) positive ALL (2002) (3)
- Pediatric Best Abstracts – Pediatric SessionCombining Clofarabine and Fludarabine with Exposure Targeted Busulfan for Pediatric Leukemia: An Effective, Low Toxicity TBI-Free Conditioning Regimen (2016) (3)
- Different outcome in older children with acute lymphoblastic leukemia with different treatment protocols in the Netherlands (2012) (3)
- Identification of Gene Expression Signatures Accurately Predicting Cytogenetic Subtypes in Pediatric Acute Myeloid Leukemia. (2008) (3)
- Clinical Relevance of Tyrosine Kinase Fusion Genes in Pediatric BCR-ABL1-like Acute Lymphoblastic Leukemia (2015) (3)
- A Retrospective Study on Inotuzumab Ozogamicin in Infants and Young Children with Relapsed or Refractory Acute Lymphoblastic Leukemia (ALL) (2019) (2)
- The evaluation of red blood cell folate and methotrexate levels during protocol M in childhood acute lymphoblastic leukemia (2020) (2)
- Erroneous Exchange of Asparaginase Forms in the Treatment of Acute Lymphoblastic Leukemia (2011) (2)
- A Randomized Trial Investigating an Exercise Program to Prevent Osteoporosis and Motor Problems during Treatment for Childhood Acute Lymphoblastic Leukemia. (2008) (2)
- mediated multiple drugresistance in children withrelapsed acutelymphoblastic leukaemia (1992) (2)
- Genetic Biomarkers to Identify the Risk of Osteonecrosis in Children with Acute Lymphoblastic Leukemia (2016) (2)
- MEF2C as Novel Oncogene for Early T-Cell Precursor (ETP) Leukemia (2010) (2)
- Modulation ofGlucocorticoid Resistance inChildhood Acute Lymphoblastic Leukemia; Preliminary Results (2001) (2)
- Individualized Tumor Response (ITR) Profiling for Drug Selection in Tailored Therapy: Meta-Analysis of 1929 Cases of Leukemia and Lymphoma. (2007) (2)
- In-Vitro Efficacy of the Deoxyguanoside Analogs Forodesine (BCX- 1777) and ARA-G in Pediatric Acute Lymphoblastic Leukemia Cells. (2008) (2)
- Drug Resistance Profile: Strongest Independent Prognostic Factor in Childhood Acute Lymphoblastic Leukemia in a BFM-Oriented Treatment Protocol (1997) (2)
- Identification of novel prognostic subgroups in childhood 11q23/MLL-rearranged acute myeloid leukemia (2009) (2)
- [Chronic renal insufficiency following childhood cancer]. (2014) (2)
- High Prevalence of Constitutional Mismatch Repair Deficiency in a Pediatric T-cell Lymphoblastic Lymphoma Cohort (2021) (2)
- Sensitivity for novel antifolates in childhood leukemia cells with resistance to methotrexate (1996) (2)
- RAS Pathway Mutations As Predictive Biomarker for Treatment Adaptation in Pediatric B-Cell Precursor Acute Lymphoblastic Leukemia (2016) (2)
- Irinotecan Induces Disease Remission in Xenograft Mouse Models of Pediatric MLL-Rearranged Acute Lymphoblastic Leukemia (2021) (2)
- B-Cell Precursor Acute Lymphoblastic Leukemia Cells Create a Self-Reinforcing Niche Independent of the CXCR4/CXCL12 Axis (2015) (2)
- Modulation of the Glycolysis Pathway Reverses Prednisolone Resistance in Pediatric Acute Lymphoblastic Leukemia Cells (2008) (2)
- Correction: Patient-derived oral mucosa organoids as an in vitro model for methotrexate induced toxicity in pediatric acute lymphoblastic leukemia (2020) (2)
- Clinical Impact of Additional Cytogenetic Aberrations and Complex Karyotype In Pediatric 11q23/ MLL -Rearranged AML: Results from an International Retrospective Study (2010) (2)
- Letter to the editor in response to "Prospective bone ultrasound patterns during childhood acute lymphoblastic leukemia" by Mussa et al. (2010) (2)
- A Treatment Protocol with Imatinib and Intensive Chemotherapy for Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia: A Single-Arm, Intergroup Study (Esphall 2010) (2018) (2)
- Hypermethylation of specific miRNA genes in MLL-rearranged infant acute lymphoblastic leukemia: Major matters at a minor scale (2010) (2)
- Polo-Like Kinase 1 (PLK1) Inhibition Reduces Cell Proliferation and Induces Apoptosis in Childhood Acute Lymphoblastic Leukemia (2012) (2)
- Selective Inhibition of Class II HDAC Isoforms 4 and 5 Provides a Promising Therapeutic Intervention for MLL-Rearranged Acute Lymphoblastic Leukemia in Infants (2021) (1)
- KTE-C19 (anti-CD19 chimeric antigen receptor [CAR] T cell therapy) in pediatric and adolescent patients with relapsed/refractory acute lymphoblastic leukemia (R/R ALL): Preliminary Results of ZUMA-4 (2017) (1)
- T-Cell Acute Lymphoblastic Leukemia Patients with Mutations in IL7Ra or Downstream RAS-MEK or PI3K-AKT Can be Collectively Targeted By Combination of RAS and AKT Inhibitors (2015) (1)
- Low Frequency of MLL-PTD Detected in Pediatric Acute Myeloid Leukemia Using MLPA Screening. (2008) (1)
- Characterization of CEBPA Mutations and Promoter Hypermethylation in Pediatric Acute Myeloid Leukemia. (2009) (1)
- Unravelling the Mirnome of MLL-Rearranged Acute Lymphoblastic Leukemia (2014) (1)
- Prednisolone Resistance in Pediatric Acute Lymphoblastic Leukemia Can Be Synergistically Overcome by Inhibition of Anti-Apoptotic MCL1 and Glycolysis (2012) (1)
- Prognostic Relevance of Recurrent Genetic Aberrations in Pediatric Acute Megakaryoblastic Leukemia (2015) (1)
- Mechanisms of methotrexate (MTX) resistance and its circumvention by novel antifolates in childhood leukemia (1997) (1)
- High Incidence of t(7;12)(q36;p13) with Involvement of HLXB9 in Infant AML. (2005) (1)
- Tumor Suppressors BTG1 and IKZF1 Cooperate during Mouse Leukemia Development and Impact Relapse Rate in Childhood Acute Lymphoblastic Leukemia (2015) (1)
- The Bone Marrow Niche of Patients with Acute Lymphoblastic Leukemia Produces No Increased Asparagine Levels In Vivo That May Lead to Clinical Asparaginase Resistance (2011) (1)
- Germline Mitochondrial DNA Mutations As a Novel First Event in Childhood Myelodysplastic Syndrome (2011) (1)
- Dexamethasone-Induced Sarcopenia and Physical Frailty in Children With Acute Lymphoblastic Leukemia: Protocol for a Prospective Cohort Study (2021) (1)
- Treatment of acute lymphoblastic leukemia in children and adolescents: Are we almost there? (2010) (1)
- PTPN11 and RAS Gene Mutation Pattern Identifies an Unique Feature of Upregulated RAS Function in Infant ALL. (2004) (1)
- Methylation of Specific Microrna Genes In MLL-Rearranged Infant Acute Lymphoblastic Leukemia: - Major Matters at a Micro Scale - (2010) (1)
- Duplication and rearrangement of the MYB oncogene in T-cellacute lymphoblastic leukemia (2007) (1)
- Combining Clofarabine and Fludarabine with Exposure Targeted Busulfan for Pediatric Leukemia: An Effective, Low Toxicity TBI-Free Conditioning Regimen (2015) (1)
- The emerging era of targeted therapy in childhood acute lymphoblastic leukemia (2010) (1)
- 3D Modeling of Novel Transforming JAK Mutations in T-Cell Acute Lymphoblastic Leukemia Reveals Altered Pseudokinase-Kinase Domain Interactions That Result in Constitutive JAK Kinase Activity (2015) (1)
- The Central Role of MAPK-ERK Signaling in IL7-Dependent and IL7-Independent Steroid Resistance Reveals a Broad Application of MEK-Inhibitors Compared to JAK1/2-Inhibition in T-ALL (2020) (1)
- Peripheral stem cell harvest using regular chemotherapy schedules in childhood cancer (2012) (1)
- A novel 6-mercaptopurine oral liquid formulation for pediatric acute lymphoblastic leukemia patients - results of a randomized clinical trial. (2014) (1)
- Correlation of childhood acute lymphoblastic leukemia subclones carrying intragenic IKZF1 deletions with relapse. (2014) (1)
- Genetic Architecture of Relapsed Pediatric B Cell Precursor Acute Lymphoblastic Leukemia Are Related to the Intensity of Upfront Therapy (2015) (1)
- Ikzf1 Deletion Status Discriminates For Outcome In Imatinibtreated Bcr-Abl1-Positive Childhood ALL (2013) (1)
- Cellular drug sensitivity of immunophenotypic subgroups of childhood acute lymphoblastic leukemia. (1993) (1)
- Expression Pattern Of Mirnas Is Not Predictive For Poor Prognosis In BCR - ABL1 -Like Childhood Acute Lymphoblastic Leukemia (2013) (1)
- Gene expression profiles predictive of outcome and age in infant acute lymphoblastic leukemia: a Children’s Oncology Group study (2012) (1)
- Targeted Therapy for ETV6-RUNX1-Driven B-Cell Precursor Acute Lymphoblastic Leukemia (2014) (1)
- Constitutive Activation of FLT3 Is a Positive Prognostic Factor in Infants with MLL-Rearranged Acute Lymphoblastic Leukemia (2015) (1)
- Aggravated Bone Density Decline after Symptomatic Osteonecrosis in Children with Acute Lymphoblastic Leukemia (2014) (1)
- Endocrine Late Sequelae in Long-Term Survivors of Childhood Non-Hodgkin Lymphoma (2011) (1)
- Continuous Exposure to Methotrexate (MTX) Overcomes Resistance in Childhood Acute Myeloid Leukemia (AML) in Vitro (1999) (1)
- Discovery of Subtype-Specific Mirnas and New MiR-Genes In Pediatric Acute Lymphoblastic Leukemia (2010) (1)
- Effect of Polymorphisms in Folate Related Genes on Side Effects of High Dose MTX Treatment in Childhood Acute Lymphoblastic Leukemia. (2004) (1)
- Personalized medicine of methotrexate therapy (2012) (1)
- FLT3 Inhibitors as Therapeutic Agents in MLL Rearranged Acute Lymphoblastic Leukemia (2011) (1)
- Cranial Irradiation Does Not Result in Pituitary-Gonadal Axis Dysfunction in Very Long-Term Male Survivors of Childhood Acute Lymphoblastic Leukemia. (2009) (1)
- Aurora Kinases in Childhood Acute Leukemia: The Promise of Aurora Kinase B As Drugable Target (2011) (1)
- The Prognostic Value of JAK2 Exon 16 Mutations in Children with Down Syndrome and Acute Lymphoblastic Leukemia. (2008) (1)
- [Blood platelets in children too few and too large: the giant platelet syndromes]. (1999) (0)
- Drug Resistance in Childhood Leukemia Multidrug Resistance-Associated Protein, P-Glycoprotein Expression, and Relationship Between Major Vault Protein/Lung Resistance Protein, (2010) (0)
- LYMPHOID NEOPLASIA STAT3 mediates oncogenic addiction to TEL-AML1 in t(12;21) acute lymphoblastic leukemia (2013) (0)
- CALM-AF10 and HOX11L2 Abnormalities Define Poor Prognostic Subgroups in Pediatric T-Cell Acute Lymphoblastic Leukemia. (2005) (0)
- PTEN/AKT Pathway Mutations Are Reciprocal to NOTCH-Activating Mutations In Pediatric T-Cell Acute Lymphoblastic Lymphoma (T-ALL) (2010) (0)
- Age-Related Changes in Hemostasis in Children with Acute Lymphoblastic Leukemia; Influences of Peg-Asparaginase Upfront and Native E Coli Asparaginase during Remission Induction Therapy. (2007) (0)
- Age-Related Differences in Cellular Drug Resistance in Children with Acute Myeloid Leukemia (AML) (2003) (0)
- Glutathione levels in leukaemic blasts (1998) (0)
- EVI1 Overexpression in Pediatric Acute Myeloid Leukemia Associated with Unfavorable Subtypes. (2008) (0)
- Small Molecule Inhibition of LARG/RhoA Signaling Blocks Migration of ETV6-RUNX1 Positive B-Cell Precursor Acute Lymphoblastic Leukemia (2015) (0)
- Brief report Asparagine synthetase expression is linked with L -asparaginase resistance in TEL-AML1 –negative but not TEL-AML1 –positive pediatric acute lymphoblastic leukemia (2005) (0)
- lymphoblastic leukemia asparaginase and asparaginase antibodies in pediatric acute Erwinia A prospective study on drug monitoring of PEGasparaginase and (2014) (0)
- Pharmacogenetic Risk Factors for Altered Bone Mineral Density and Body Composition in Pediatric Acute Lymphoblastic Leukemia. (2009) (0)
- MYELOID NEOPLASIA Recurrent abnormalities can be used for risk group strati fi cation in pediatric AMKL: a retrospective intergroup study (2016) (0)
- Fibroblast growth factor receptor signaling in pediatric B-cell precursor acute lymphoblastic leukemia (2019) (0)
- Abstract 1925: High-throughput drug library screening identifies potent drugs and novel drug targets for high-risk acute leukemia in children (2018) (0)
- Prognostic Significance of Molecular-Cytogenetic Abnormalities in Pediatric T-ALL Is Not Explained by Immunophenotypic Differences. (2007) (0)
- Development of Osteonecrosis Is Associated with Difference in Upregulation of Antithrombin, Protein C and Protein S after Four Weeks of Dexamethasone during Induction Treatment in Childhood Acute Lymphoblastic Leukemia. (2007) (0)
- Hydrocortisone to reduce dexamethasone-induced neurobehavioral side effects in children with acute lymphoblastic leukemia – results of a double-blind, randomized controlled trial with cross-over design (2023) (0)
- myeloid leukemia gene mutations in childhood acute Wilms tumor 1 Clinical relevance of (2009) (0)
- Effective re-induction therapy with dasatinib and clofarabine in relapsed Philadelphia chromosome positive acute lymphoblastic leukemia (2012) (0)
- Abstract 4347: Anaplastic lymphoma kinase (ALK) expression is an independent prognostic factor in neuroblastoma patients and correlates well with ALK inhibitor response in vitro: (2011) (0)
- P078 No evidence for mutation independent constitutive activation of FLT3 in juvenile myelomonocytic leukemia (2007) (0)
- Genetic Variants of Ataxia Telangiectasia Mutated (ATM) and Susceptibility for Childhood T-Lineage Acute Lymphoblastic Leukemia. (2004) (0)
- Evi1 Overexpression Is Associated with Unfavorable Subtypes in Pediatric Acute Myeloid Leukemia (2009) (0)
- O22: A new recurrent 9q34 duplication in pediatric T-cell acute lymphoblastic leukemia (2005) (0)
- Identification of a Novel T-ALL Entity with NKX2-1/NKX2-2 Rearrangements (2010) (0)
- international study -rearranged AML patients: results of an MLL novo pediatric 11q23/ Prognostic significance of additional cytogenetic aberrations in 733 de (2011) (0)
- Absence of JAK2 V617F Activating Mutations in Children with Acute Megakaryoblastic Leukemia with and without Down Syndrome. (2006) (0)
- ACCURATE PREDICTION OF CYTOGENETIC SUBGROUPS IN PEDIATRIC ACUTE MYELOID LEUKEMIA WITH GENE EXPRESSION PROFILING; A CRITICAL VALIDATION STUDY (2008) (0)
- Microrna Expression Profiling In Pediatric Acute Myeloid Leukemia Reveals a Tumor-Suppressive Role Of Mir-9 Associated With Translocation (8;21) (2013) (0)
- A New Recurrent 9q34 Duplication in Pediatric T-Cell Acute Lymphoblastic Leukemia. (2005) (0)
- MLL -Rearranged ALL Cells Are Highly Dependent On the Expression of EP300-Interacting Inhibitor of Differentiation 1 (EID1) (2012) (0)
- The long-term impact of in vitro drug sensitivity testing on risk stratification and treatment outcome in acute lymphoblastic leukemia of childhood (CoALL 06-97) Running title: risk stratification by in vitro drug testing (2010) (0)
- Pharmacogenetics and Drug Resistance in ALL (2012) (0)
- A competitive template RT-PCR to measure mRNA encoding for folate metabolizing enzymes, such as thimidylate synthase, in leukemia and colon cancer (1999) (0)
- in pediatric T-cell acute lymphoblastic leukemia activation mechanism HOXA fusion as a new SET-NUP214 The recurrent (2013) (0)
- Negative prognostic factors in acute myeloid leukemia: P-glycoprotein (P-gp) and CD34 expression (1994) (0)
- Expression of Mir-196b Is Not Exclusively MLL-Driven but Especially Linked to Activation of HOXA Genes in Children with Acute Lymphoblastic Leukemia. (2009) (0)
- Effects of polymorphisms in folate-related genes on methotrexate sensitivity and risk of acute lymphoblastic leukemia (2007) (0)
- AGE-RELATED CHANGES BY ASPARAGINASE ON COAGULATION AND FIBRINOLYSIS IN CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) (2007) (0)
- Constitutive Expression of MEF2C, LYL1, or LMO2 in CD34+ HSCs Blocks the in Vitro Differentiation before the T-Cell Commitment Point and Could be Oncogenic in Early T-Cell Progenitor ALL (2015) (0)
- O023 Oncogenic IL-7R gain-of-function mutations in childhood T-ALL (2011) (0)
- Identification of Candidate Oncogenes and Chromosomal Breakpoint Sequencing By Targeted Locus Amplification in T-Cell Acute Lymphoblastic Leukemia (2015) (0)
- to chromosomal abnormalities Cellular drug resistance in childhood acute myeloid leukemia is related (2011) (0)
- EMP1, a Novel Poor Prognostic Factor In Pediatric Leukemia Regulates Prednisolone Resistance, Cellular Proliferation, Migration and Adhesion (2013) (0)
- No Evidence of MDR1 Gene Related Clonal Selection in Relapsed or Refractory Acute Myeloid Leukemia (AML) (2003) (0)
- Kringle IV Encoding Domains in the Apo(a) Gene and Serum Lipoprotein(a) Level Do Not Contribute to Avascular Necrosis of Bone (AVN) in Acute Lymphoblastic Leukemia. (2004) (0)
- relapse in childhood acute lymphocytic leukemia Raised blast glutathione levels are associated with an increased risk of (2013) (0)
- IKZF1 deletions in Pediatric Acute Myeloid Leukemia (2014) (0)
- NUTM1 Is a Rare but Recurrent Fusion Gene Partner in B Cell Precursor Acute Lymphoblastic Leukemia Associated with Increased Expression of Genes on Cytoband 10p12.31 (2018) (0)
- Population Pharmacokinetics and Pharmacodynamics of Ciprofloxacin Prophylaxis in Pediatric Acute Lymphoblastic Leukemia Patients (2020) (0)
- 234 Role of mitochondrial DNA mutations in childhood MDS (2011) (0)
- Clinical Trials and Observations (2005) (0)
- No evidence of selection of a MDR1 gene related drug resistant clone in relapsed/refractory AML (2000) (0)
- A randomised trial investigating an exercise programme to prevent reduction of bone mineral density and impairment of motor performance during treatment for childhood acute lymphoblastic leukaemia (2009) (0)
- SESSION 45: MALE FERTILITY PRESERVATION (2012) (0)
- Collaboration Between MiR-125b, MiR-100 and MiR-99a Induces Vincristine Resistance in Childhood TEL-AML1-Positive Acute Lymphoblastic Leukemia (2012) (0)
- EBV-DRIVEN LYMPHOID NEOPLASMS ASSOCIATED WITH ALL MAINTENANCE THERAPY: AN INTERNATIONAL OBSERVATINAL STUDY (2022) (0)
- Childhood Leukemias: Assays and molecular determinants of cellular drug resistance (2006) (0)
- The impact of pre-transplant disease load on outcome in children with acute lymphoblastic leukaemia in the current era (2013) (0)
- Glioblastoma therapy in the elderly: one age does not fi t all (2012) (0)
- Asparagine levels in the bone marrow of patients with acute lymphoblastic leukemia during asparaginase therapy (2013) (0)
- MTT assay with improved culture conditions In vitro drug sensitivity of cells from children with leukemia using the (2011) (0)
- BIOLOGY AND TREATMENT OF ACUTE LYMPHOBLASTIC LEUKEMIA respond (0)
- Unique MicroRNA Profiles in Childhood Acute Lymphoblastic Leukemia. (2006) (0)
- Invitro anthracycline cross-resistance pattern inchildhood acute lymphoblastic leukaemia (1995) (0)
- Assessment of the Aryl Hydrocarbon Receptor Gene as a Therapeutic Target in Childhood T-Lineage Acute Lymphoblastic Leukemia. (2005) (0)
- Anthracycline resistance in childhood leukemia (1993) (0)
- Sequential Measurement of Bone Mineral Density Identifies Ongoing Recovery of Detrimental Bone Mass in Very Long Term Adult Survivors of Childhood Cancer (2012) (0)
- Should We Use a Desensitization Protocol In Acute Lymphoblastic Leukemia Patients With Silent Inactivation Of Pegasparaginase (2013) (0)
- Comparison of MRD Monitoring By IG/TR Rearrangement and BCR/ABL1 Transcript in Ph+ Pediatric Acute Lymphoblastic Leukemia Patients Treated with Imatinib in the Esphall Study (2014) (0)
- LONGITUDINAL CHANGES IN BODY MASS INDEX AND BODY COMPOSITION AMONG 417 ADULT SURVIVORS OF CHILDHOOD CANCER (2012) (0)
- lymphoblastic leukemias Activating FLT3 mutations in CD4+/CD8- pediatric T-cell acute (2013) (0)
- Purine nucleotide interconversion enzymes in childhood leukemia: relation with cell cycle and clinical outcome. (1994) (0)
- Interfant-99 protocol Outcome of congenital acute lymphoblastic leukemia treated on the (2013) (0)
- The Clinical Relevance of Cellular Drug Resistance Testing in Childhood Acute Myeloid Leukemia (AML) (1999) (0)
- Role of folylpolyglutamate hydrolase in methotrexate resistance in childhood leukemia (1997) (0)
- Population Pharmacokinetic of Native Escherichia Coli Asparaginase. (2009) (0)
- High IGSF4 expression In Pediatric Acute Monoblastic Leukemia with t(9;11) (2010) (0)
- Hydrocortisone does Not Influence in Vitro Glucocorticoid Sensitivity of Acute Lymphoblastic Leukemia Blasts (2014) (0)
- RNA Expression Levels of (Co)Chaperone Molecules of the Glucocorticoid Receptor Are Not Related to In Vitro Prednisolone Resistance in Childhood ALL. (2004) (0)
- No evidence for constitutively activated FLT3 in juvenile myelo-monocytic leukemia (2006) (0)
- Final height and IGF1 in adult survivors of Wilms tumour. (2013) (0)
- Single-cell transcriptomics predicts relapse in MLL-rearranged acute lymphoblastic leukemia in infants (2020) (0)
- 232 Relevance of WT1 expression, mutations and single nucleotide polymorphisms in juvenile myelomonocytic leukemia (2011) (0)
- Specific promoter methylation identifies distinct subgroups of MLL -rearranged infant ALL, defines clinical outcome and provides therapeutic options (2010) (0)
- IER3 expression in childhood myelodysplastic syndrome (2011) (0)
- THE EUROPEAN ROADMAP TO HORIZON 2020 FOR CHILDREN AND ADOLESCENTS WITH CANCER - A LONG TERM SUSTAINABLE STRATEGY (2015) (0)
- Reply to ‘ATM variants and predisposition to childhood T-lineage acute lymphoblastic leukaemia’ by Gumy-Pause et al. (2006) (0)
- Study )rearranged acute lymphoblastic leukemia: results from the Interfant-99 MLL ( mixed-lineage-leukemia poor prognostic subgroup of infants with Improved outcome with hematopoietic stem cell transplantation in a (2010) (0)
- Classification of pediatric acute myeloid leukemia utilizing gene expression profiling (2008) (0)
- LYMPHOID NEOPLASIA IKZF 1 status as a prognostic feature in BCR-ABL 1 – positive childhood ALL (2014) (0)
- Determinants of bone mineral density in long-term adult survivors of childhood cancer (2013) (0)
- Role of MRD in Ph+ Pediatric Acute Lymphoblastic Leukemia Patients Treated with and without Tirosine Kinase Inhibitor in the Esphall Study (2012) (0)
- Microrna-106b~25 Cluster Is Involved in Relapsed MLL-Rearranged Pediatric AML (2014) (0)
- Exome Sequencing Identifies Pxdn and DSP As Recurrently Mutated Genes in Infant ALL Patients Carrying a MLL-AF4 Translocation (2014) (0)
- 74 : IL-7R: Mutations in T-ALL and polymorphisms in autoimmunity (2013) (0)
- leukemia rearranged infant acute lymphoblastic - Ara-C sensitivity in MLL gene metabolizing enzymes explains - Differential mRNA expression of Ara-C (2013) (0)
- No Evidence for Constitutively Activated FLT3 in Juvenile Myelo-Monocytic Leukemia. (2005) (0)
- Future perspectives on minimizing bone density reduction in pediatric acute lymphoblastic leukemia. (2010) (0)
- Single Cell Transcriptomics Predicts Relapse in Infants with Acute Lymphoblastic Leukemia (2019) (0)
- Minimal Residual Disease and IKZF1 As Predictors of Relapse, and Increased Treatment Related Mortality in Down Syndrome Acute Lymphoblastic Leukemia: A Unique and Large International Matched Case-Control Study (2019) (0)
- Expression of P73 Splice Variants Correlates to Resistance to DNA Damaging Drugs in Childhood T-Lineage Acute Lymphoblastic Leukemia. (2004) (0)
- 4TH INTERNATIONAL SYMPOSIUM ON LEUKEMIA AND LYMPHOMA-MOLECULAR PHARMACOLOGY AND NEW TREATMENT MODALITIES (2000) (0)
- lymphoblastic leukemia cells Genomewide identification of prednisolone-responsive genes in acute (2013) (0)
- Identification of new cancer genes involved in lymphomagenesis (2007) (0)
- Primary Acute Lymphoblastic Leukemia Cells Create a Drug-Resistant Niche By Tunneling Nanotube Signaling with Mesenchymal Stromal Cells (2014) (0)
- Enforced Expression Of MiR-24, MiR-126 and MiR-365 Does Not Alter Cellular Viability In TCF3-Rearranged Leukemia (2013) (0)
- Prognostic Value of Immunophenotype In Infant ALL – Results of the INTERFANT'99 Study (2010) (0)
- DNA Methylation Profiling of Pediatric AML Reveals That Hypomethylation of MN1 Is Characteristic of Inv(16) AML and a Driver of MN1 Overexpression (2014) (0)
- Abstract 2490: High AXL promotes migration in non-MYCN amplified neuroblastoma cell lines (2012) (0)
- Effect of Treatment in a Specialized Pediatric Hemato-Oncology Setting on 5-Year Survival in Acute Lymphoblastic Leukemia: A Quasi-Experimental Study (2022) (0)
- MEK Inhibition Is a Promising Therapeutic Strategy for MLL -Rearranged Infant ALL Patients Carrying RAS Mutations (2014) (0)
- Aberrant expression of miR-196b and miR-708 is characteristic for but not reflecting the differentiation status of MLL-rearranged and T-cell acute lymphoblastic leukemia in children. (2008) (0)
- ALL promoter usage is not linked to glucocorticoid resistance in childhood Glucocorticoid-induced glucocorticoid-receptor expression and (2006) (0)
- resistance leukemia: prognostic significance and relation to cellular drug FLT3 internal tandem duplication in 234 children with acute myeloid (2013) (0)
- Cost-Effectiveness of Treatment of Childhood Acute Lymphoblastic Leukemia with Pegasparaginase and Erwinia Asparaginase: The Impact of Expensive Chemotherapy (2012) (0)
- The Role of Mutations in the Deoxycytidine Kinase (dCK) Gene in the Development of Acute Myeloid Leukemia (AML) Towards Relapsed and/or Refractory Disease (2003) (0)
- Determinants of Low Bone Mineral Density after Childhood Cancer (2014) (0)
- Discovering new oncogenic aberrations in T-cell acute lymphoblastic leukemia (2010) (0)
- Infant Acute Lymphoblastic Leukemia Rob Pieters (2010) (0)
- MLL Gene Rearranged Acute Lymphoblastic Leukemia (2018) (0)
- Bone mineral density at diagnosis determines fracture rate in children-treated according to the DCOG-ALL9 protocol (2013) (0)
- Abstract 148: Development of a DNA methylation array normalization method for analyzing demethylating treatment effects in paired samples (2010) (0)
- expression in relapsed or refractory acute myeloid leukemia related clonal selection and P-glycoprotein function and - MDR1 gene (2013) (0)
- P1051 DECREASED EXPRESSION OF INTESTINAL SPECIFIC TRANSCRIPTION FACTORS DURING METHOTREXATE INDUCED INTESTINAL DAMAGE (2004) (0)
- AML lacking evidence for neurofibromatosis inactivation in patients with pediatric TALL NF 1 Leukemia-associated (2008) (0)
- ALL expression, in children with B-cell precursor CRLF2 deletion, but not high IKZF1 signature and BCR-ABL1-like Independent prognostic value of (2013) (0)
- Molecular diagnosis of polymorphism of cytochrome P450 isoenzymes for optimalisation of chemotherapy in childhood cancer (2007) (0)
- outcome, and provides therapeutic options MLL-rearranged infant acute lymphoblastic leukemia, influences clinical Specific promoter methylation identifies different subgroups of (2013) (0)
- Reduced Treatment for Good Risk Pediatric Acute Lymphoblastic Leukemia Patients Leads to a Decrease in Infectious Morbidity. (2009) (0)
- [Bone necrosis as a sequela of chemotherapy in hematologically malignant disorders]. (1989) (0)
- 233 IER3 in childhood myelodysplastic syndrome (2011) (0)
- Pharmacokinetics and Pharmacodynamics of High Dose Methotrexate in Children with Acute Lymphoblastic Leukemia and down Syndrome: a Case Cohort Study. (2008) (0)
- Analyzing the MLL Recombinome. (2004) (0)
- myeloid leukemia: results of an international retrospective study Novel prognostic subgroups in childhood 11q23/MLL-rearranged acute (2013) (0)
- Distinct Methylation Patterns among Infants with MLL Rearranged Acute Lymphoblastic Leukemia. (2007) (0)
- Differential gene expression in response to the repression of MLL-AF4 and MLL-ENL. (2015) (0)
- CONTRIBUTION OF THE MUCOSAL IMMUNE SYSTEM TO METHOTREXATE INDUCED INTESTINAL DAMAGE: PG2-09 (2005) (0)
- Leukemia Cells with a BCR-ABL1-Like signature and/or IKZF1 deletions, but Not High CRLF2 Expression, Are Predictive of an Unfavorable Prognosis in Childhood B Cell Precursor Acute Lymphoblastic Leukemia (2012) (0)
- Impaired bone mineral density in adult survivors of childhood cancer: a literature review (2015) (0)
- The Potential of Aurora Kinases A and B As Therapeutic Targets in Pediatric Acute Leukemia (2012) (0)
- T-Cell Receptor Vß CDR3 Oligoclonality Frequently Occurs in Childhood Refractory Cytopenia and Severe Aplastic Anemia. (2007) (0)
- UvA-DARE ( Digital Academic Repository ) Quantitative analysis of minimal residual disease by PCR in childhood acute lymphoid leukemia (2007) (0)
- Quality of Life Evolvement During the First Year of Treatment for Childhood Acute Lymphoblastic Leukemia (2010) (0)
- 92 MLL gene rearranged leukemia: from biology to therapy (2003) (0)
- 1 Targeting FLT 3 in primary MLL gene rearranged infant acute lymphoblastic leukemia (2005) (0)
- A Prospective Study on Incidence, Risk Factors and Long-Term Outcome of Osteonecrosis in 694 Patients with Pediatric Acute Lymphoblastic Leukemia (2011) (0)
- Abstract 768: MCL1 and glycolysis synergistically induce prednisolone resistance, which can be therapeutically reversed (2012) (0)
- High-Throughput Drug Library Screening in Primary KMT2A-Rearranged Infant ALL Cells Favors the Identification of Drug Candidates That Activate P53 Signaling (2022) (0)
- Deletions in B-Cell Development Genes in Down Syndrome ALL: IKAROS Causes Poor Outcome (2009) (0)
- Epigenetic drug combination induces genome-wide demethylation and altered gene expression in neuro-ectodermal tumor-derived cell lines (2013) (0)
- Somatic Mutations and Polymorphisms of the Glucocorticoid Receptor Gene Are Not Related to Glucocorticoid Resistance in Childhood ALL. (2004) (0)
- The Limited Screening Value of Insulin-Like Growth Factor-I in 610 Very Long Term Adult Survivors of Leukemia and Other Types of Childhood Cancer (2011) (0)
- [Electron spin resonance tomography of the musculoskeletal system]. (1987) (0)
- Germ-Line Genetic Variations in TP53 and Risk for Pediatric Acute Lymphoblastic Leukemia. (2004) (0)
- Contribution of the mucosal immune system to methotrexate induced intestinal damage (2006) (0)
- Poor Survival of CD34 Positive and CD13/33 Positive Patients in Pediatric T-Cell Acute Lymphoblastic Leukemia Is Not Explained by Expression of Multidrug Resistance Genes. (2007) (0)
- CNOT1 Microrna Single Nucleotide Polymorphism (SNP) Determines the Occurrence of Methotrexate Related Mucositis in Pediatric Acute Lymphoblastic Leukemia (2015) (0)
- Single nucleotide polymorphisms of the vitamin D receptor 5′-end influence bone mineral density and body composition during treatment of paediatric acute lymphoblastic leukaemia (2009) (0)
- Ovarian function is associated with obesity in very long-term female survivors of childhood cancer (2013) (0)
- Immunophenotyping Versus Morphological Evaluation Of Fresh and Stabilized Cerebrospinal Fluid As Diagnostic Tool For CNS Involvement In Childhood Acute Lymphoblastic Leukemia (2013) (0)
- The C677T Polymorphism in the Methylenetetrahydrofolate Reductase (MTHFR)Gene Is an Important Determinant of Bone Mineral Density in Pediatric Acute Lymphoblastic Leukemia Patients. (2004) (0)
- Identification of Prognose Genetic Factors in Pediatric T-cell Acute Lymphoblastic Leukemia (2007) (0)
- Second Neoplasms After Treatment of Childhood Acute Lymphoblastic Leukemia (2012) (0)
- Abstract 1624: Methotrexate resistance in relation to treatment outcome in childhood acute lymphoblastic leukemia (2015) (0)
- Identification of mutations in WFS 1 in Dutch patients with Wolfram syndrome (2002) (0)
- Clinical Relevance of NOTCH1 and FBXW7 Mutations in DCOG and COALL T-ALL Patient Cohorts. (2009) (0)
- Vitamin A Does Not Enhance the Antileukemic Effect of Vincristine, Daunorubicin, and 6-Thioguanine in Acute Lymphoblastic Leukemia Cells (1994) (0)
- The Histone Deacetylase Inhibitor Panobinostat (LBH-589) Exerts Anti-Leukaemic Activity in a MLL-Rearranged ALL Xenograft Mouse Model (2014) (0)
- Unfavorable Prognostic Value of IKAROS but Not CRLF2 in Children with BCRABL1-positive Acute Lymphoblastic Leukemia, (2011) (0)
- Overexpression of BRE in Pediatric MLL-Rearranged Acute Myeloid Leukemia Associated with t(9;11)(p22;q23). (2009) (0)
- Childhood Leukemias: Genetics and cellular drug resistance in acute leukemia (2010) (0)
- Pharmacokinetic and Pharmacodynamic Effects of PEG-Asparaginase in Newly Diagnosed Childhood Acute Lymphoblastic Leukemia: Results from a Single Agent Window Study. (2007) (0)
- ALL positive childhood - BCR-ABL1 status as a prognostic feature in IKZF1 (2014) (0)
- Implementation of paediatric precision oncology into clinical practice: The Individualized Therapies for Children with cancer program ‘iTHER’ (2022) (0)
- Pediatric hematopoietic stem cell transplantation (2007) (0)
- Outcome of the Rotterdam-84 CNS-ALL Chemotherapy Protocol without Radiotherapy for Isolated Central Nervous System Relapsed Acute Lymphoblastic Leukemia. (2004) (0)
- In-Vitro Cellular Drug Resistance in Acute Non-Lymhoblastic Leukemia: Comparisons Between Adults and Children (2001) (0)
- The interaction between folate homeostasis and MRPs/ABCCs and BCRP/ABCG2 expression: role in cellular drug resistance (2007) (0)
- HIGH IGSF4 EXPRESSION DISCRIMINATIVE FOR MLL-AF9 PEDIATRIC ACUTE MYELOID LEUKEMIA WITH FAB M5 (2010) (0)
- T-cell receptor (TCR)Vβ repertoire analysis: A valuable diagnostic tool for pediatric MDS and SAA? (2006) (0)
- Childhood Acute Lymphoblastic Leukemia In Vitro Cellular Drug Resistance and Prognosis in Newly Diagnosed (2013) (0)
- Minimal Residual Disease, Long-Term Outcome, and IKZF1 Deletions in Down Syndrome Acute Lymphoblastic Leukemia in a Matched Cohort Study (2021) (0)
- Molecular alterations in the reduced folate carrier gene, multidrug resistance protein-mediated efflux and folate compartmentation: impact on cellular folate homeostasis and activity of antifolate drug in childhood leukemia (2000) (0)
- Molecular Aberrations in 107 Children with Myelodysplastic Syndrome (MDS). (2012) (0)
- Treatment of MLL gene rearranged Acute Lymphoblastic Leukemia (2006) (0)
- MiRNA Profiles in Acute Lymphoblastic Leukemia: Rather a Characteristic for the Leukemia Subtype Than a Reflection of Its Differentiation Status. (2007) (0)
- The Integrated Immunological Signature of Refractory Cytopenia of Childhood (RCC) (2015) (0)
- How I Treat How I treat infant leukemia (2018) (0)
- Genetic Variation is Involved in Impairment of Bone Mineral Density in Long-Term Adult Survivors of Childhood Cancer (2015) (0)
- A Novel Approach for Analyzing Gene Expression Profiles Defines Two Distinct Subgroups of t(4;11) Positive Infant Acute Lymphoblastic Leukemia Patients. (2007) (0)
- High expression of CD40 on BCP-ALL blasts is an independent risk factor associated with improved survival and enhanced capacity to upregulate the death receptor CD95 (2008) (0)
- Free Papers (2014) (0)
- Is Recovery of Gonadal function possible in Very Long-Term Adult Male Survivors of Hodgkin's Lymphoma? (2012) (0)
- Coagulation and Fibrinolysis in Children with Acute Lymphoblastic Leukemia; Influences of Dexamethasone and L-Asparaginase. (2005) (0)
- Influence of unilateral adrenalectomy on set point of Hypothalamic-pituitary-adrenal-axis in long-term survivors of childhood nephroblastoma and neuroblastoma (2012) (0)
- CD34+CD19−, CD34+CD19+ and CD34−CD19+ Cells May All Have Leukemia-Initiating Potential in NOD/Scid Mice. (2006) (0)
- Influence of bisphosphonates or recombinant human parathyroid hormone on in vitro sensitivity of acute lymphoblastic leukemia cells to chemotherapy (2021) (0)
- Comparison of the Predictive Value of MRD and PVA Score in Pediatric ALL. (2008) (0)
- Down syndrome leukemia and normal peripheral blood mononuclear cells in children with Different drug sensitivity profiles of acute myeloid and lymphoblastic (2001) (0)
- 116 SENSITIVITY TO PURINE ANTAGONISTS IN CHILDHOOD LEUKEMIA ASSESSED BY THE AUTOMATED MTT-ASSAY (1988) (0)
- lymphoblastic leukemia cells Inhibition of glycolysis modulates prednisolone resistance in acute (2011) (0)
- Genetic Abnormalities Underlying B-Cell Development Are Characteristic for a New Subgroup of Childhood Precursor B-ALL with a Very Poor Prognosis (2008) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Robrecht Pieters?
Robrecht Pieters is affiliated with the following schools:
